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Abstract 
Coenzyme A (CoA) is an essential cofactor required for hundreds of metabolic processes. 
Because it is such a critical cofactor, CoA levels are tightly regulated. In the fasted state and in diabetic 
mice, the concentration of CoA increases dramatically in the liver. This phenotype is associated with 
constitutively low CoA degradation, a process that is emerging as a potentially important mechanism for 
CoA regulation. Nudt7 and Nudt19 are two mammalian peroxisomal enzymes with CoA-degrading 
activity, which are highly expressed in the liver and kidney, respectively. Limited information is available 
on the biochemistry of Nudt7 and Nudt19; the structural basis for their distinct features and the extent to 
which Nudt7 contributes to maintaining homeostatic CoA levels in vivo are currently unknown. We used 
a combination of techniques including mutagenesis, molecular modeling, and enzymatic assays on 
purified proteins, plus metabolomics and measurement of fatty acid oxidation in whole tissue 
homogenates and intact hepatocytes to: 1) characterize the biochemical, structural, and regulatory 
properties of Nudt7 and Nudt19 and 2) determine the effects that manipulations of Nudt7 expression have 
on CoA levels and lipid metabolism in mouse liver. This research establishes the importance of Nudt7-
dependent CoA degradation in the regulation of select acyl-CoA species and the output of peroxisomal 
metabolic pathways such as bile acid synthesis and peroxisomal fatty acid oxidation.
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Chapter I: Literature review 
Introduction 
Coenzyme A (CoA) is an essential and ubiquitous cofactor that plays a key role in energy 
metabolism. It is estimated that about 4% of all cellular enzymes utilize CoA as a cofactor and that it may 
be involved in at least 100 metabolic reactions (1,2). CoA was identified from hog liver in 1947 and its 
structure later determined in 1953 (3,4). The structure of CoA consists of a 3’,5’-ADP, 
phosphopantothenate, and cysteamine. The reactive thiol group of CoA reacts with carboxylic acids to form 
thioesters, thus CoA acts as an acyl carrier to move various fatty acids across membranes and during 
intermediate steps of numerous metabolic pathways (2). The CoA pool also includes acetyl-CoA, the acetyl-
group donor for protein acetylation, an essential post-translational modification that regulates the function 
of histones and thousands of other proteins. Formation of short, medium, and long chain acyl-CoA 
thioesters is essential for metabolic pathways found in the cytosolic, mitochondrial, and peroxisomal 
compartments of the cell (5). Because of its ability to regulate the output of several metabolic pathways, 
the concentration of CoA in various tissues is tightly regulated and adjusted depending on the metabolic 
state. In particular, CoA levels increase in the transition from the fed to the fasted state to support the switch 
from glucose to fatty acid oxidation in metabolically flexible organs like the liver and kidneys. Importance 
of such a tight regulation of CoA concentration is underscored by the fact that abnormally high and 
dysregulated CoA levels in the liver actively contribute to the hyperglycemia that characterizes mouse 
models of type 2 diabetes, while increased malonyl-CoA in the muscle of obese subjects is associated with 
increased lipogenesis (6,7). Conversely, inhibition of CoA synthesis by genetic manipulations or treatment 
with the chemical inhibitor Hopan, causes changes in global protein acetylation and hypoglycemia (8-10). 
Combined, this evidence underscores the importance of regulating CoA levels.  
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Subcellular distribution of CoA 
Mitochondria, peroxisomes, and the cytosol/nucleus contain separate pools of CoA that are 
important for the processes that occur in each of these cellular compartments. The highest concentration of 
CoA is found in the mitochondria, estimated at 4 to 5 mM (11,12). CoA is important in the mitochondria 
for several metabolic pathways such as ketogenesis, and the oxidation of pyruvate and fatty acids. The 
second subcellular CoA pool (approximately 0.1 mM) is the cytosolic pool which is important for complex 
lipid synthesis that occurs there (12). The cytosolic CoA pool can freely equilibrate with the nuclear pool 
since all CoA species are small enough to cross the nuclear pores. Within the nucleus, acyl-CoAs contribute 
to histone acetylation and regulation of gene expression for pathways such as spermatogenesis and 
ketogenesis (13). For example, long-chain acyl (LCA)-CoAs are potent down regulators of the nuclear 
thyroid hormone receptor (14,15) and various acyl-CoAs are able to regulate transcriptional activity of 
hepatocyte nuclear factor 4α (HNF-4α) (16). The final and smallest pool of CoA (approximately 0.3 to 0.7 
mM) is found in the peroxisomes. The pool of CoA in this compartment is used for the oxidation of lipids 
that cannot be processed in the mitochondria, bile acid synthesis, and for the synthesis of ether lipids. 
(12,17). It is currently unknown how the individual pools of CoA are regulated.  
The endoplasmic reticulum (ER) also contains its own pool of acetyl-CoA. Acetyl-CoA is 
transported into the ER through acetyl-CoA transporter 1 (AT-1) (18). Once inside the ER, acetyl-CoA 
lysine acetyltransferases use the acetyl-CoA to acetylate lysine residues on a long list of proteins involved 
in autophagy and protein quality control. Reduced acetyl-CoA import into the ER leads to 
neurodegenerative disorders, disruptions of the immune system, and development of various cancers (19). 
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Synthesis of CoA 
Regulation of the biosynthetic 
pathway is a major mechanism to adjust 
CoA levels in the entire cell. CoA is 
synthesized from pantothenate (vitamin 
B5), ATP, and cysteine through a series 
of five reactions (4). First, pantothenate 
kinase (PanK) phosphorylates 
pantothenate to form 4’-
phosphopantothenate (Fig. 1.1). Next, 
4’-phosphopantothenoylcysteine 
(PPCS) synthase catalyzes the 
condensation of 4’-
phosphopantothenate with cysteine to 
form 4’-phosphopantothenoylcysteine. 
Then 4’-phosphopantothenoylcysteine 
decarboxylase (PPCDC) 
decarboxylates this intermediate forming 4’-phosphopantetheine. In the fourth step of the biosynthetic 
pathway, phosphopantetheine adenylyltransferase (PPAT) converts 4’-phosphopantetheine into 
dephospho-CoA. Finally, dephospho-CoA kinase  (DPCK) phosphorylates dephospho-CoA at the 3’-OH 
of the ribose sugar producing CoA (2). In eukaryotes, the last two steps are catalyzed by a bifunctional 
enzyme called CoA synthase (Coasy). The subcellular localization of Coasy is still a matter of debate. This 
enzyme has been localized to both the mitochondrial outer membrane with the active site exposed to the 
cytosol and to the mitochondrial matrix. In the first case, CoA would be synthesized in the cytosol; in the 
Figure 1.1. The regulation of CoA through synthesis 
and degradation. Pantothenate is converted into 4’-
Phosphopantothenate by the PanKs in the CoA synthesis 
pathway. CoA is degraded into 3’,5’-ADP and 4’-
Phosphopanteteine by Nudt7 and Nudt19. 
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second case, CoA would be synthesized in the mitochondrial matrix and require a specific transporter to 
exit this organelle and reach other subcellular compartments.  
Regulation of CoA synthesis 
CoA biosynthesis is controlled by PanK, the enzyme that catalyzes the first and rate-limiting step 
in the pathway. Regulation of PanK occurs through feedback inhibition by the cellular levels of free CoA 
and CoA thioesters (20-22). In mammals, there are three Pank genes that are responsible for the expression 
of four catalytically active PanK enzymes: PanK1α, PanK1β, PanK2, and PanK3 (23). The four PanK 
isoforms share >80% sequence identity but possess distinct N-termini that direct them to different 
subcellular compartments. Both of the PanK1 isoforms are expressed from the Pank1 gene through 
alternative initiation sites (24), and are the least sensitive to feed-back inhibition by CoA species. PanK1α 
resides in the nucleus and is highly expressed in kidney and heart. PanK1β is cytosolic and highly expressed 
in the liver. PanK2 is localized to the mitochondria in humans and found in the cytosol in mice (25,26). In 
humans, this isoform is highly expressed in the brain. PanK3, another cytosolic isoform, is ubiquitously 
distributed and, together with PanK2, is the most stringently regulated PanK isoform (23,27).  Both the 
human PANK2 and mouse PanK2 are potently inhibited by acetyl-CoA and the inhibition is released by 
palmitoylcarnitine (26). Competition between acetyl-CoA and palmitoylcarnitine for the active site allows 
PanK2 to act as a “sensor” of the status of mitochondrial fatty acid oxidation enabling the cell to increase 
or decrease CoA biosynthesis in response to mitochondrial metabolism (26). PanK3 shares approximately 
79% amino acid identity to PanK1β, is localized to the cytosol, and most abundant in the liver and kidneys. 
Whereas PanK1α and PanK1β are more refractory to inhibition by CoA species, PanK3 is inhibited by to 
free CoA, acetyl-CoA, malonyl-CoA, and palmitoyl-CoA. Though PanK3 is expressed at the highest levels 
in the liver compared to other tissues, it only accounts for about 30% of the total PanK protein in the liver.  
PanK1α/β accounts for 70% of the liver’s total PanK protein pool.  
In addition to negative feedback by CoA on the PanKs, various hormones and metabolites can 
modulate the rate of this step of the CoA biosynthetic pathway. Glucose (28), palmitate, pyruvate, β-
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hydroxybutyrate and insulin (29,30) inhibit CoA biosynthesis while glucagon and glucocorticoids stimulate 
CoA synthesis (31).  These early studies utilized flux analysis to measure the production of CoA through 
the pathway, therefore the mechanism by which these metabolites regulate CoA synthesis remains to be 
elucidated.   
Problems associated with impaired CoA synthesis 
Disruption of CoA biosynthesis leads to severe metabolic consequences. Pank1-/- mice exhibit a 
40% decrease in the concentration of CoA levels in the liver and the inability to sustain the increase in the 
rate of fatty acid β-oxidation that characterizes the fed-to-fasted transition in this organ (32). This, in turn, 
blunts the ability of the liver to synthesize glucose de novo (gluconeogenesis) during a fast, a process that 
is activated by the products (NADH and acetyl-CoA) of fatty acid oxidation. As a consequence, Pank1-/- 
mice exhibit fasting hypoglycemia (32). This phenotype is milder compared to mice treated with HoPan, a 
pantothenate analog that inhibits all the PanK isoforms. HoPan-treated mice exhibit an 80% reduction in 
liver and kidney CoA levels and rapidly die of hypoglycemia, even if food is available (10). Mutations of 
the PANK2 gene result in the development of Pantothenate Kinase-Associated Neurodegeneration (PKAN), 
a rare autosomal recessive disorder characterized by dystonia and accumulation of iron in the basal ganglia 
generally occurring before 10 years of age (33). Pank2-/- mice have been generated, but they do not show 
any sign of neurodegeneration. Instead, these mice exhibit male sterility and retinal degeneration  (34). 
Generation of Pank1/Pank2-/- mice exhibit a more severe decrease in the concentration of CoA in both the 
liver and brain indicating that both isoforms can compensate for each other. The double knockout mice also 
exhibit severe hypoglycemia, liver triglyceride accumulation, and hyperketonemia leading to death by 3 
weeks of age (35).  
Inhibition of the final steps of CoA synthesis also cause abnormalities. A recent study of Coasy in 
cells have found that knockdown of Coasy leads of hyperacetylation of mitotic proteins result in mitotic 
defects and multi-nucleation (36). While CoA levels were significant decreased upon Coasy knockdown, 
an additional function of the enzyme was identified from this study; during mitosis Coasy interacts with the 
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histone acetyltransferase, CREB-binding protein (CBP), and inhibits its activity. Loss of Coasy resulted in 
persistent CBP acetylation of its downstream target, Targeting Protein for Xklp2 (TPX2), resulting in 
prolonged TPX2 stabilization, activation of aurora kinase, and mitotic defects. Generation and analysis of 
Coasy in a mouse model has yet to be completed.   
Problems associated with supraphysiological CoA levels 
The link between CoA levels and gluconeogenesis was confirmed in a recent study on leptin-
deficient (Lep-/-) mice, a well-established model of obesity-induced type 2 diabetes (37). Lep-/- mice are 
obese and contain abnormally high hepatic CoA levels that no longer respond to nutritional regulation. 
Deletion of Pank1 in Lep-/- mice decreased liver CoA levels and significantly improved hyperglycemia and 
hyperinsulinemia, independent of changes in body weight. Overexpression of human PANK2 in a 
transgenic mouse model led to elevated skeletal muscle CoA levels resulting in reduced skeletal muscle 
mass, reduced ATP levels, increased oxidative stress, impaired exercise tolerance, and reduced grip strength 
(38). Interestingly, vitamin B12 deficiency has also been found to cause a significant increase in total liver 
CoA levels and a large accumulation of propionyl-CoA and methylmalonyl-CoA; however, no downstream 
metabolic consequences of this increase were found (39). 
Degradation of CoA/acyl-CoAs 
Degradation is another possible way to rapidly modulate the concentration of cellular CoA. In the 
liver and kidneys, degradation of CoA is necessary in the transition from the fasted to the fed state to 
decrease the levels of the cofactor that accumulated due to a starvation stimulated increase in synthesis. 
The existence of a pathway for CoA degradation is also supported by the fact that mice treated with HoPan 
(the chemical inhibitor of the PanK enzymes) exhibit a rapid decrease in liver and kidney CoA levels, 
indicating the presence of an enzyme(s) that could break down (acyl-)CoA.  Early studies in rat liver 
identified three possible enzymes capable of degrading CoA. Fractionation and kinetic analysis provided 
evidence that one such enzyme was localized to the lysosomes, one was in the nuclear fraction, and one 
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was found in the microsomal fraction (40). The lysosomal enzyme was found to dephosphorylate CoA 
while the microsomal and nuclear enzymes were both thought to be pyrophosphatases capable of 
hydrolyzing CoA and dephospho-CoA (41). The degradation of CoA by these enzymes was thought to be 
a sequence of four steps starting with the removal of the 3’-phosphate to form dephospho-CoA, followed 
by degradation to 4’-phosphopantetheine, then dephosphorylation to form pantetheine, and finally 
degradation of pantetheine into pantothenic acid and cysteamine (42).  
Nudix hydrolases 
Nudix hydrolases are a superfamily of diphosphohydrolases found in most eukaryotes, prokaryotes, 
archaea, and viruses. The members of this family catalyze the hydrolysis of the bond between a nucleoside 
diphosphate linked to another moiety X (Nudix). All members of this family possess the signature Nudix 
box motif – Gx5Ex5(UA)xRE(UA)xEExGU – that is essential for binding a divalent cation, typically 
magnesium, required for the hydrolysis of phosphate-phosphate or phosphate-carbon bonds. Members of 
this family were originally recognized as exhibiting a “housecleaning” function as they degrade metabolites 
that could be potentially hazardous if they accumulate in the cell (43). The number of Nudix hydrolases in 
each organism varies from zero to 30. The substrate specificity of these enzymes is determined by other 
specific motifs in the sequence. For example, Nudix hydrolases specific for CoA and CoA thioesters contain 
the amino acid sequence LLTxR[SA]x3Rx3Gx3FPGG (PROSITE accession number PS01293), near the 
Nudix box motif (44). CoA-degrading Nudix hydrolases are conserved from bacteria to humans. The first 
CoA-degrading Nudix hydrolase discovered was Pcd1p, a Saccharomyces cerevisiae Nudix hydrolase. 
Studies of this enzyme determined that it degrades free CoA and some acyl-CoA species into 3’,5’-ADP 
and 4’-phosphopantetheine (Fig. 1.1).  Pcd1p was also determined to be the first peroxisomal Nudix 
hydrolase as evidenced by the presences of a peroxisomal targeting sequence (PTS) 2 and cellular 
localization studies (45). Soon after, other CoA-degrading enzymes were discovered in Deinococcus 
radiodurans, and the peroxisomes of Caenorhabditis elegans, mice, and humans (46-49).  Currently, there 
are two available structures of these CoA-degrading enzymes. The first is that of D. radiodurans. The 
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structure of the enzyme with Mg2+ bound has provided some insight into possible key residues for catalysis 
and has helped define the CoA-binding motif through modeling of the substrate into the putative active site. 
The Nudix motif, a helix-loop-helix structure, contains three glutamate residues that coordinate the 
magnesium ion. Within the CoA-binding motif are an arginine and a serine residue that are potentially 
involved in the coordination of the leaving products (phosphopantetheine or 3’,5’-ADP) after hydrolysis 
(50). The crystal structure of human NUDT7 has recently been solved (PDB ID: 5T3P) (51), however, the 
crystal structure of the human enzyme does not contain bound Mg2+. Both enzyme structures were solved 
without a CoA substrate.  Thus, the contribution of the CoA motif to CoA binding and the organization of 
the CoA binding site in these enzymes are currently unknown. 
Mammalian CoA-degrading Nudix hydrolases 
There are currently only two confirmed peroxisomal CoA-degrading Nudix hydrolases found in 
mammals, Nudt7 and Nudt19. Nudt7 is found in highest quantities in the liver, with low but detectable 
levels in brown adipose tissue and heart. Nudt19 is expressed in highest concentrations in the kidneys (49). 
Both Nudt7 and Nudt19 have a C-terminal PTS1 sequence which directs them to the peroxisomes (48,49). 
Nudt7 has a molecular weight of 27 kDa, a typical size for a Nudix hydrolase, while Nudt19 is larger at 
about 42 kDa. Nudt7 and Nudt19 exhibit only a modest sequence similarity. One key difference in the 
amino acid sequence of Nudt7 and Nudt19 is the presence of an approximate 45 amino acid insertion in the 
Nudix motif of Nudt19. Though small insertions have been observed in the Nudix box of other Nudix 
hydrolases, this large insertion sequence is unique to Nudt19. The purpose of the sequence is currently 
unknown. Analysis of Nudt7 activity has shown that it is a promiscuous enzyme, catalyzing the degradation 
of free CoA as well as short- and medium-chain acyl-CoA species. In contrast, Nudt19 is much more 
selective, catalyzing the degradation of free and medium-chain acyl-CoAs but not, for example, acetyl-CoA 
(49,52). Nudt7 mRNA and activity change in the liver in response to the metabolic state. The amount of 
Nudt7 mRNA and activity is high in the fed state and decreases in the fasted state, correlating to the increase 
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to hepatic CoA levels. It has remained undetermined to what extent, if any, the change in Nudt7 activity in 
the peroxisomes contributes to the change in liver CoA levels and/or peroxisomal metabolism. 
Acyl-CoA thioesterases 
In addition to complete degradation by the Nudix hydrolases, CoA thioesters can also be 
hydrolyzed to free CoA and free fatty acids by acyl-CoA thioesterases (ACOT) (53,54) to modulate certain 
metabolic pathways. There are two families of ACOTs. Type I ACOTs are members of the α/β-hydrolase 
protein family and exhibit a conserved “catalytic triad” of a serine, histidine, and aspartic acid in their active 
sites (55). Type II ACOTs have lower sequence similarity but all contain the conserved “HotDog domain”; 
a structural motif consisting of a seven-stranded anti-parallel β-sheet “bun” wrapped around a hydrophobic 
five-turn α-helical sausage, with a third layer of “condiment” loops over the helix (53). ACOTs from both 
families are localized to the various subcellular compartments. Six different ACOTs (ACOT3, 4, 5, 6, 8, 
and 12) in mice and two (ACOT4 and 8) in humans localize to the peroxisomes, suggesting that hydrolysis 
of acyl-CoAs may be a way to quickly modulate lipid metabolism in the peroxisomes independently of 
CoA biosynthesis. Each of the peroxisomal ACOTs has a defined substrate specificity but combined, they 
all contribute to the hydrolysis of short-, medium-, and long-chain acyl-CoAs, bile acid-CoAs, and 
branched-chain acyl-CoAs. Murine Acot3, Acot4, Acot5, and Acot8 are thought to be involved in 
regulating peroxisomal β-oxidation (56,57). Acot3 is specific for long-chain acyl-CoAs, Acot5 is specific 
for medium-chain acyl-CoAs, and Acot4 hydrolyzes only succinyl-CoA and glutaryl-CoA. Human ACOT4 
exhibits activity against all of these substrates and is thought to have “replaced” the activity of Acot3 and 
Acot5 in mice (58). It has been hypothesized that these enzymes hydrolyze acyl-CoAs to allow the free 
fatty acid to be exported from the peroxisomes and utilized in mitochondrial β-oxidation and then Nudt7 
and Nudt19 hydrolyze the resulting free CoA to prevent a toxic buildup. 
CoA-linked peroxisomal metabolism 
While peroxisomes have been historically associated with the containment and breakdown of 
hydrogen peroxide that is formed from the oxidation of other substrates, there are several other metabolic 
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processes that occur within these organelles. These processes include β-oxidation of very long-chain fatty 
acids, branched-chain fatty acids, bile acid intermediates, and long-chain dicarboxylic acids, α-oxidation of 
fatty acids, glyoxylate detoxification, ether phospholipid biosynthesis, and bile acid synthesis. Many of 
these processes require free CoA for various steps in the pathways and result in the formation of short chain 
acyl-CoA species. For example, the thiolase enzymes require a molecule of free CoA for each round of β-
oxidation to bind to the shortened fatty acid from which acetyl-CoA has been released.  Similarly, sterol 
carrier protein X (SCPx) requires free CoA for the last step of bile acid formation, which releases propionyl-
CoA (59,60). Above all else, peroxisomal acyl-CoA synthetases require free CoA to activate fatty acids 
and steroid derivatives when they enter the peroxisomes so that they can be further metabolized (61).   
Peroxisomal bile acid synthesis 
Peroxisomes play a critical role in the synthesis of bile acids, as illustrated by the bile acid 
abnormalities observed in individuals with peroxisomal biogenesis disorders (62,63). The two primary bile 
acids chenodeoxycholic acid (CDCA) and cholic acid are formed from cholesterol. Cholesterol is modified 
on the sterol side chain through several steps and activated to a CoA thioester in the ER. Once conjugated 
to CoA, the C27 bile acid intermediate can enter the peroxisome to complete its biosynthesis and be 
conjugated to taurine or glycine (59). Once the mature bile acid is conjugated to taurine or glycine, it is 
excreted into the bile. The last step in the biosynthesic process, catalyzed by SCPx, requires an additional 
molecule of free CoA and results in the formation of proponyl-CoA. This step has been previously identified 
as a key step in completion of bile acid synthesis, as loss of SCPx results in an accumulation of bile acid 
intermediates (64,65). Interestingly, it is known that onset of obesity and Type 2 diabetes, which are 
associated with elevated, unregulated CoA levels, leads to an elevation in the total bile acid pool even upon 
administration of bile acid sequestrants (66). However, there has never been any direct connection 
established between peroxisomal CoA levels and the rate of bile acid synthesis. 
Peroxisomal β-oxidation and the connection to the mitochondria 
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Both mitochondria and peroxisomes contribute to fatty acid oxidation; however, each organelle 
contains distinct sets of enzymes. β-Oxidation of the majority of short-, medium-, and long-chain fatty acids 
is localized primarily to the mitochondria and supports the production of ATP through oxidative 
phosphorylation (67). β-Oxidation of very long-chain fatty acid occurs almost exclusively in the 
peroxisomes since mitochondria lack a very long-chain acyl-CoA synthetase to activate these fatty acids to 
the correspondent acyl-CoAs. Once activated, the very long-chain acyl (VLCA)-CoAs are then shortened 
to medium-chain acyl (MCA)-CoAs through the peroxisomal β-oxidation pathway. Shortening of VCLA-
CoAs in the peroxisomes has been well established as a crucial and irreplaceable step. Disruption of the 
gene coding for fatty acyl-coenzyme A oxidase (ACOX), the first enzyme in the peroxisomal β-oxidation 
pathway, results in the development of peroxisomal metabolic disorders (68-71). These disorders are 
characterized by a buildup of very long chain fatty acids in the blood, growth retardation, sterility, and 
neurological abnormalities.  
Once the VLCA-CoAs are shortened to MCA-CoAs, carnitine octanoyltransferase (Crot) then 
converts the MCA-CoAs into MCA-carnitines, which can cross the peroxisomal and mitochondrial 
membrane and feed into the mitochondrial fatty acid oxidation pathway (17,72). Thus, mitochondria and 
peroxisomes are metabolically interconnected and there is evidence that reactions in one organelle may 
affect the other and vice versa (73). Mitochondrial fatty acid oxidation is linked to gluconeogenesis and 
ketogenesis, pathways that allow the liver to release glucose and ketone bodies in the blood to provide fuels 
in the fasted state. Previous studies have confirmed that the amount of (acyl-)carnitines present will affect 
these processes; an increase in (acyl-)carnitines in the liver will increase fatty acid oxidation, 
gluconeogenesis, and ketogenesis (74,75). Because Nudt7 and Crot compete for MCA-CoAs as substrates, 
the activity of Nudt7 could potentially affect the flux of MCA-carnitines into the mitochondria.  
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Objective 
CoA is a key regulator of energy metabolism and cell function. Because CoA is such a critical 
cofactor, maintaining a homeostatic level is essential to keep the metabolic processes it is involved with at 
optimal rates. It has been established that synthesis is an important mechanism to control CoA levels; 
however, degradation is another mechanism that may rapidly adjust CoA levels to the metabolic state. The 
objective of this study is to determine the in vitro biochemical characteristics of the CoA-degrading enzyme 
Nudt7 and its role in liver metabolism. To fulfill this objective, we will use a two-pronged approach of in 
vitro biochemistry and in vivo mouse studies. Characterizing the in vitro biochemical features such as 
substrate specificity, regulation, and key catalytic domains/residues will provide insight into the role of 
Nudt7 in the liver. Comparing the biochemical characteristics of Nudt7 to Nudt19, the CoA-degrading 
enzyme expressed in kidneys, may help answer the question of why two isoforms exist in the same 
subcellular compartment but different organs. Determining the structure of Nudt7 and Nudt19 with 
modeling and/or crystallography will provide additional information about the substrate binding domains 
and the fold of a unique insertion found in Nudt19.  Overexpressing Nudt7 in the livers of mice will provide 
an in vivo approach to analyzing the involvement of Nudt7 in regulating hepatic CoA levels and thus, 
hepatic metabolic pathways.  Analyzing the levels of total CoA in the livers of mice overexpressing Nudt7 
will determine in decrease in the enzyme activity upon fasting contributes to the significant increase in liver 
CoA. Analyzing changes in the composition of the acyl-CoA pool and the metabolome of livers 
overexpressing Nudt7 will identify the in vivo substrates and potential metabolic pathways that Nudt7 
regulates in the liver.  
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Abstract 
 CoA is the major acyl carrier in mammals and a key cofactor in energy metabolism.  Dynamic 
regulation of CoA in different tissues and organs supports metabolic flexibility.  Two mammalian Nudix 
hydrolases, Nudt19 and Nudt7, degrade CoA in vitro.  Nudt19 and Nudt7 possess conserved Nudix and 
CoA signature sequences, and specifically hydrolyze the diphosphate bond of free CoA and acyl-CoAs to 
form 3’,5’-ADP and 4'-(acyl)phosphopantetheine.  Limited information is available on these enzymes, but 
the relatively high abundance of Nudt19 and Nudt7 mRNA in the kidney and liver, respectively, suggests 
that they play distinct roles in the regulation of CoA levels in these organs.   
Here, we analyzed Nudt19-/- mice and found that deletion of Nudt19 elevates kidney CoA levels in 
mice fed ad libitum, indicating that Nudt19 contributes to the regulation of CoA in vivo.  Unlike what 
observed for the regulation of Nudt7 in the liver, Nudt19 transcript and protein levels in the kidney did not 
differ between fed and fasted states.  Instead, we identified chenodeoxycholic acid (CDCA) as a specific 
Nudt19 inhibitor that competed with CoA for Nudt19 binding but did not bind to Nudt7.  Exchange of the 
Nudix and CoA signature motifs between the two isoforms dramatically decreased their kcat. Furthermore, 
substitutions of conserved residues within these motifs identified amino acids playing different roles in 
CoA binding and hydrolysis in Nudt19 and Nudt7.   
Our results reveal that the kidney and liver each possesses a distinct peroxisomal CoA 
diphosphohydrolase.   
Introduction 
Coenzyme A (CoA) is an obligate cofactor utilized as an acyl carrier in hundreds of metabolic 
reactions.  Numerous CoA thioesters are also involved in the post-translational modification of histones 
and thousands of other proteins (1-5). Three major subcellular CoA pools are found in the cytosol, 
mitochondria, and peroxisomes to support specific metabolic pathways (6,7).  These include, among others, 
fatty acid synthesis in the cytosol, the TCA cycle and oxidation of long-chain and medium-chain fatty acids 
in the mitochondria, and bile acid conjugation and oxidation of very long-chain and branched-chain fatty 
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acids in the peroxisomes.  A dedicated pool of acetyl-CoA is also found in the endoplasmic reticulum where 
it is involved in protein quality control and autophagy (8), while nuclear acyl-CoAs, which freely equilibrate 
with the cytosolic pool across the nuclear pores, contributes to the regulation of gene expression (5).   
Tight control over the concentration of CoA in different organs is essential to maintain normal 
metabolism and organ function.  Indeed, elevated CoA levels in the liver of diabetic mice promote excessive 
gluconeogenesis and hyperglycemia (9), while a supraphysiological concentration of CoA in skeletal 
muscle leads to decreased ATP levels and exercise performance (10).  Adverse consequences are also 
associated with lower than normal CoA levels.  Decreased synthesis of this cofactor in the nervous system 
is associated with a rare neurological disorder in humans (11,12), while decreased synthesis of CoA in the 
liver leads to fasting hypoglycemia and hepatic triglyceride accumulation (13).  Dynamic regulation of CoA 
within the normal physiological range is important to support the metabolic reprogramming that underlies 
the capacity to respond to changes in the metabolic state.  For example, the increase in CoA that 
characterizes the fed-to-fasted transition in the liver is driven by the activation of the biosynthetic pathway 
and is required to sustain the high rates of hepatic fatty acid oxidation and gluconeogenesis under fasting 
conditions (13,14).  On the other hand, the net decrease in the concentration of CoA observed upon 
refeeding after a fast requires both inhibition of de novo CoA synthesis and active degradation of the 
cofactor accumulated in the fasted state.   
The existence of a CoA-degradation pathway in the liver and kidneys is supported by the fact that 
mice treated with an inhibitor of the CoA biosynthetic pathway, exhibit a dramatic reduction in hepatic and 
renal CoA, indicating rapid CoA turnover in these tissues (15).  Liver and kidneys contain high transcript 
levels of two Nudix hydrolases, Nudt7 and Nudt19, respectively, which exhibit CoA diphosphohydrolase 
activity in vitro (16,17).  Nudix hydrolases hydrolyze the diphosphate bond of a variety of substrates 
consisting of a nucleoside diphosphate linked to another moiety, x (18,19).  All members of the Nudix 
superfamily contain the conserved Nudix box motif G1N[5X]E7N[7X]R15NE16NXXE19NE20NXG22NU (where 
U is a hydrophobic residue, X is any residue and superscript N denotes the position of a residue of the 
signature motif within a specific protein sequence) (20,21).  Additionally, Nudix hydrolases that 
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specifically hydrolyze CoA also contain a putative CoA binding motif, 
(L/M)(L/F)TXR(S/A)[3X](R/K)[3X]G[3X]FPGG (PROSITE accession number PS01293, formerly 
UPF0035), upstream of the Nudix box motif (22).  The crystal structure of human NUDT7 has recently 
been released (PDB ID: 5T3P) (23).  Similar to the structure of the bacterial homolog from D. radiodurans 
(24), the crystal structure of the human enzyme does not contain CoA bound.  Thus, the contribution of the 
CoA motif to CoA binding and the organization of the CoA binding site in these enzymes are currently 
unknown.  
 Independent studies and approaches have demonstrated the localization of Nudt7 in the 
peroxisomes (17,25).  Nudt7 mRNA and protein levels in the liver are regulated by the nutritional state and 
are inversely correlated with the tissue concentration of CoA (9,26).  Additionally, overexpression of a 
catalytically active, cytosolic form of Nudt7 has also recently been shown to cause a decrease in CoA levels 
in vivo (25).   
 Significantly less is known about Nudt19.  Nudt19 exhibits modest sequence similarity to Nudt7 
(about 30%), is larger than a typical Nudix hydrolase, including Nudt7, and contains a unique 45-49 amino 
acid insertion of unknown function within its Nudix box (16).  This enzyme, also known as RP2p, was 
originally reported to be a kidney protein whose transcript levels were robustly upregulated by androgens 
(27).  Later, recombinant Nudt19 was shown to specifically hydrolyze CoA species (16), although modest 
activity against capped RNA has also been detected (28).  Based on proteomics studies, Nudt19 localization 
has been reported in both peroxisomes and mitochondria (16,29); however it is currently unclear whether 
the enzyme has dual localization or exclusively resides in one of the two subcellular compartments, and 
which one.  Given the presence of dedicated CoA pools and complementary metabolic processes in 
peroxisomes and mitochondria, this distinction is important to gain insight into the physiological role of 
Nudt19, even in relation to the other mammalian isoform, Nudt7.  Indeed, it is presently unclear whether 
Nudt7 and Nudt19, which seem to be differentially expressed in liver and kidneys, differ in key aspects of 
their function. 
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We have investigated the effect of Nudt19 deletion on CoA levels, the localization of this enzyme 
in intact cells, and its regulation by selected metabolites.  Additionally, we used a combination of 
computational modeling, substrate docking and site directed mutagenesis to identify residues involved in 
CoA binding and hydrolysis in Nudt19, and analyzed the role of equivalent residues in Nudt7.  We show 
that Nudt19 is a peroxisomal enzyme that contributes to the regulation of kidney CoA levels in vivo and 
provide evidence supporting the conclusion that the CoA binding sites of Nudt19 and Nudt7 are different.   
Material and methods 
Materials 
Reagents were purchased from the following suppliers: oligonucleotides, Lipofectamine 2000, cell 
culture reagents Alexa Flour 555 and HRP-conjugated goat anti-rabbit IgG from ThermoFisher Scientific; 
restriction enzymes, DNA polymerases and the Q5® Site-Directed Mutagenesis Kit from New England 
Biolabs; HEK 293 cells from the American Type Culture Collection, and the GAPDH antibody from Cell 
Signaling.  The PMP70 antibody was purchased from Sigma-Aldrich.  The antibody against the full-length 
mouse Nudt19 was raised in rabbit and purified by antigen affinity chromatography.  The Nudt7 antibody 
was generated as previously described (9).  mBB-CoA was synthesized from free CoA and 
monobromobimane (Echelon Biosciences) as described by Shimada et al. (30). The conversion of free CoA 
to mBB-CoA was >99.0%, as estimated by HPLC.  All other reagents were of analytical grade or better 
and were purchased from Sigma-Aldrich or Fisher Scientific, unless otherwise stated. 
Animal Studies 
Nudt19tm1(KOMP)Vlcg embryos, obtained by replacing the Nudt19 gene with a ZEN-UB1 cassette 
harboring the lacZ reporter and neo resistance gene, were purchased from the Knockout Mouse Project 
(KOMP) repository and implanted into pseudopregnant foster mothers by the Transgenic Animal Core 
Facility at West Virginia University.  The progeny was screened for the deletion of the Nudt19 gene by 
multiplex PCR analysis using the Accustart II PCR Genotyping Kit (QuantaBio) and the following KOMP 
primers: Reg-NeoF (GCAGCCTCTGTTCCACATACACTTCA), Reg-Nudt19-R 
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(TTCACAACCTGCCAAAATGGCTACC), Reg-Nudt19-wtF2 
(GGAAACGGGAACAGAGAAACAGG) and Reg-Nudt19-wtR 
(AAGGACTCAACTCTCACCCTAAGCG).  The Nudt19 knockout allele yielded a product of 466 bp.  
Although smaller than the size of 584 bp predicted by the KOMP repository, this 466 bp amplicon contained 
the expected 3' end of the ZEN-UB1 cassette (124 bases) and a sequence corresponding to the genomic 
region downstream of the Nudt19 gene (342 bp), as confirmed by sequencing.  The wild type allele yielded 
a product of the expected size of 185 bp.  Homozygous Nudt19-/- mice and wild-type C57BL6/N littermate 
controls were obtained through heterozygous x heterozygous breeding.  Mice were fed a standard chow diet 
(Tekland 2018S) and maintained at a room temperature of 72.0 ± 0.3 °F, room humidity of 40% ± 2%, and 
a 12-h light, 12-h dark cycle, with the dark cycle starting at 18:00 h.  For experiments that required fasting, 
mice were transferred to clean cages containing floor grids, and food was removed for the indicated time.  
All studies were conducted on 10-14 week-old male mice and were approved by the Institutional Animal 
Care and Use Committees of West Virginia University.   
CoA Analysis, Immunoblotting and RT-PCR 
The concentration of total CoA (free CoA plus CoA thioesters) in kidney homogenates was 
determined after conversion of the cofactor to the monobromobimane derivative, as previously described 
(25).  For western blot analysis, flash frozen tissues were homogenized in ice-cold 
radioimmunoprecipitation assay (RIPA) buffer supplemented with protease inhibitors (Biotool), and 
centrifuged at 10,000 x g for 10 min at 4°C.  Proteins were fractionated on 4-12% bis-Tris polyacrylamide 
gels and transferred onto PVDF membranes. The GAPDH antibody was used at a 1:3000 dilution; the 
Nudt7 and Nudt19 antibodies were used at a 1:10,000 dilution.  Bound primary antibodies were detected 
by chemiluminescence with HRP-conjugated goat anti-rabbit IgG at a 1:45,000 dilution.  RNA was isolated 
from flash frozen tissue as previously described (31).  Following the removal of genomic DNA with Turbo 
DNAse-free kit (Thermo Fisher Scientific), Nudt19 mRNA levels were quantified in triplicate by RT-PCR 
using the Quantitect SYBR Green RT-PCR kit (Qiagen) and the primers previously reported (31).  The 
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relative abundance of the Nudt19 mRNA was calculated using the CT method, and the amount (2-∆CT) 
reported relative to the mRNA of beta-glucuronidase (GusB). 
Plasmid Construction and Mutagenesis  
Wild type mouse Nudt7 and Nudt19 were expressed as N-terminal hexahistine-tagged proteins 
from plasmids pKM204 (25) and pKM249, respectively.  Plasmid pKM249 was a kind gift from Dr. 
Suzanne Jackowski, St. Jude Children's Research Hospital.  The above plasmids were mutagenized with 
the Q5® Site-Directed Mutagenesis Kit to generate single point Nudt7 and Nudt19 mutants, and a Nudt19 
deletion mutant lacking amino acids 58-103.  Insertion of the correct mutations was confirmed by 
sequencing analysis by the Genomics Core Facility at West Virginia University.  Sequences encoding 
Nudt7 and Nudt19 chimeras were custom synthesized (ThermoFisher Scientific) to contain NdeI and NotI 
restriction sites at the 5' and 3' ends, respectively, codon-optimized for expression in E. coli and subcloned 
into pET-28a(+) (Millipore).  For the expression and localization of mouse Nudt19 in HEK 293 cells, 
custom pcDNA3.1(+)-derived constructs (GenScript) were assembled to express Nudt19 proteins, codon-
optimized for expression in human cells, with N- or C-terminal GFP tags.   
Protein Purification, Analytical Gel Filtration Chromatography and Isothermal Titration Calorimetry 
(ITC) 
All Nudt7 and Nudt19 proteins with N-terminal hexahistidine tags were expressed in BL21 
CodonPlus (DE3)-RIPL (Agilent Technologies) cells, following induction with 1 mM isopropyl β-D-1-
thiogalactopyranoside and growth for 18–20 h at 18-25°C.  For enzymatic assay, the enzymes were purified 
as previously described (25).  Fractions containing ∼90% pure enzymes were combined and dialyzed 
overnight at 4°C in buffer containing 20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 1 mM EDTA and 1 mM 
dithiothreitol.  Glycerol was added to a final concentration of 50% and proteins were stored at -20°C.  
Protein samples analyzed by analytical gel filtration chromatography were loaded (50 µl) onto a Superdex 
75 10/300 GL column and eluted at 0.3 ml/min with 50 mM Tris-HCl, 150 mM NaCl, pH 8.0.  Protein 
elution was monitored by measuring the absorbance at 280 nm.  For ITC studies, the purification procedure 
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included three chromatographic steps to increase the purity of the proteins to >98%, and the hexahistidine 
tag was removed.  Briefly, cell pellets were lysed in 50 mM Na2HPO4/NaH2PO4, pH 8.0, 300 mM NaCl, 
10 mM imidazole and centrifuged at 13,000 rpm for 45 min at 4°C.  The clarified supernatant was allowed 
to bind to the Ni-NTA resin for 2 h with stirring, before the suspension was transferred into a column.  The 
resin-bound proteins were washed with 50 mM Na2HPO4/NaH2PO4, pH 8.0, 300 mM NaCl, 20 mM 
imidazole, followed by elution with wash buffer containing 50-100 mM of imidazole.  Protein-containing 
fractions were combined, dialyzed in buffer A (50 mM Na2HPO4/NaH2PO4, pH 8.0, 200 mM NaCl) and 
incubated with 0.04 U/ml thrombin (Sigma-Aldrich) overnight at room temperature to remove the 
hexahistine tag.  The salt concentration of the protein samples was then lowered with an additional dialysis 
step in buffer B (50 mM Na2HPO4/NaH2PO4, 50 mM NaCl), before applying the proteins onto a 
Resource15Q anion exchange column equilibrated in buffer B.  Proteins were eluted with a 0-100% gradient 
of buffer C (50 mM Na2HPO4/NaH2PO4, pH 8.0, 500 mM NaCl), and the fractions containing the proteins 
of interested were pooled, dialyzed in buffer A and concentrated to 5 ml.  The concentrated protein samples 
were subsequently loaded onto a HiLoad 26/60 Superdex 75 pg size exclusion column equilibrated in buffer 
A, eluted in the same buffer, concentrated and stored at -80°C.  
Binding affinity of wild type Nudt7 and Nudt19 for CDCA was measured by ITC at 25ºC using a 
VP-ITC instrument (Microcal Inc, Northhampton, MA) and 1.4 ml of purified Nudt7 and Nudt19 dialyzed 
in ITC buffer (30 mM PIPES pH 7.5, 50 mM NaCl, 2 mM MgCl2) and diluted to 124 µM and 55.5 µM, 
respectively.  Protein solutions were degassed for at least 20 minutes.  CDCA stock solutions were prepared 
in the same ITC buffer.  After an initial 2 μl injection of CDCA solution with a 240 second equilibration 
time, the compound was titrated in 30 injections of 10 μl each, added at 300 second intervals. The duration 
of each injection was 12 seconds and the filter period 2 seconds. The stirring speed and Feedback Mode/gain 
option were set up to 300 rpm and “High” respectively.  The heat evolved at 25°C after each ligand injection 
was obtained by integration of the calorimetric signal after subtracting the average heat of dilution. Binding 
parameters were determined from titration binding curves using the MicroCal Data Analysis software 
(Malvern, Westborough, MA). 
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Enzymatic Assays 
 The CoA diphosphohydrolase activity of the recombinant enzymes was assayed, in duplicate, as 
previously described (25), with minor modifications.  The standard assay contained 10 ng of recombinant 
Nudt7 or 30 ng of Nudt19, 100 mM Tris-HCl pH 8.0, 0.1 mg/ml gamma globulin, an optimized 
concentration of MgCl2, which was 4 mM for Nudt7 or 10 mM for Nudt19, and 250 µM of free CoA or 
acyl-CoA substrates, in a total volume of 40 µl.  The reactions were incubated at 37°C for 10 min and 
stopped by the addition of perchloric acid.  Following neutralization with potassium carbonate, the reaction 
mixtures were diluted 5-fold with water, and the UV-visible 3’,5’-ADP product was separated and 
quantified by high performance liquid chromatography (HPLC) coupled with UV detection on a 4.6 x 150 
mm, 3 μm C-18 column (Acclaim 120) kept at 35°C.  Elution was performed at 0.7 ml/min as follows: 0–
2.5 min, 100% buffer A (50 mM KH2PO4); 2.5–9.0 min linear gradient to 50% B (100% acetonitrile); 9.0–
10.0 min isocratic at 50% B; 10.0–15.0 min linear gradient from 50% B to 75% B; 15.0–19.0 min isocratic 
at 75% B; 19.0–32.0 min return to 100% A, and column equilibration.  A standard curve of 3’,5’-ADP 
(Sigma-Aldrich) subjected to the same reaction conditions was used to quantify the amount of product 
formed.  For each mutant and chimeric enzyme, protein curves were generated to select concentrations 
within the activity linear range.  The length of the assay was also extended to 2 h for mutants exhibiting 
marginal activity. The kinetic parameters KM, Vmax, and kcat were determined using free CoA as the 
substrate, with concentrations ranging from 31.25 µM to 10 mM, and obtained from curves fitted to 
Michaelis-Menten equation using GraphPad Prism 6 (GraphPad Software).  
To monitor the production of 3',5'-ADP in kidney extracts, flash-frozen tissue (∼50 mg) was 
homogenized in 750 µl of 20 mM Tris-HCl pH 8.0.  The homogenate was incubated on ice for 10 min and 
centrifuged at 20,000 xg for 10 min.  The supernatant was loaded on to a PD10 column equilibrated in 20 
mM Tris-HCl pH 8.0, to remove the small molecules. The eluted proteins (50-200 µg) were incubated with 
250 µM free CoA for 5 min at 37 °C.  The reactions were then stopped and analyzed as described above. 
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Immunofluorescence 
HEK 293 cells were cultured at 37°C and 5% CO2 in phenol red-free Opti-MEM I medium 
supplemented with 4% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin and 0.25 µg/ml amphotericin B.  
To localize Nudt19, cells were seeded on 12 mm coverslips at low density and grown in the same medium 
to about 80% confluence.  Transfections were performed with 1.25 µg of plasmid DNA using 
Lipofectamine 2000, as per manufacturer's instructions.  Where indicated, cells were incubated with 
Mitotracker Orange CMTMRos at a concentration of 25 nM for 30 min at 37oC.  The cells were fixed 
with 4% paraformaldehyde, and blocked in PBS containing 5% FBS and 0.3% Triton X-100 for 1 h at room 
temperature.  The PMP70 antibody was used at a 1:1000 dilution in 1% BSA, 0.3% Triton-X100 for 1 h at 
room temperature.  Following 10 washes with PBS, the cells were incubated for 1 h at room temperature 
with Alexa Flour 555 donkey anti-mouse IgG, used at a dilution of 1:1000 in 1% BSA, 0.3% Triton X- 100.  
Slides were mounted using Prolong Gold Antifade with DAPI (ThermoFisher).  Imaging experiments were 
performed in the West Virginia University Imaging Facilities using a Nikon A1R/N SIM-E confocal 
microscope.  Image analysis was conducted using ImageJ.  
Molecular Modeling 
Homology models with bound Mg2+ were built using the software suite YASARA (32) 
(www.yasara.org).  The models showing the expected orientation of E16N, E19N and E20N with respect to the 
Mg2+ ion were selected and prepared for docking studies with free CoA by adding hydrogens at pH 7.4 in 
the modeling program MOE 2016 (www.chemcomp.com). After an induced fit docking step, the top five 
poses were evaluated for the correct relative orientation of the diphosphate moiety of free CoA, the bound 
Mg2+ and Nudt19 R34 or NUDT7 R60.  Sequence alignments were obtained using Clustal W (33) and 
combined with secondary structure elements using ESPript 3 (34).  The Nudt19 model and the crystal 
structures of human NUDT7 and the bacterial CoAse were aligned using Phenix Ensembler (35). 
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Statistical Analysis 
Unless otherwise stated, all data are reported as the mean with ± the standard deviation. Statistical 
significance was calculated by unpaired two-tailed Student's t test using GraphPad Prism 6 (GraphPad 
Software). 
Results 
Nudt19 Regulates Kidney CoA Levels in Vivo 
Previous work has shown that Nudt19 hydrolyzes free CoA and acyl-CoAs to 3',5'-ADP and 4'-
(acyl)phosphopantetheine in vitro (16).  We confirmed these findings by measuring the activity of 
recombinant Nudt19 against several acyl-CoAs and comparing it to the better characterized Nudt7 (17,25) 
(Fig. 2.1A and 1B).  We determined that the optimal concentration of MgCl2 for Nudt7 and Nudt19 was 4 
and 10 mM, respectively, when free CoA was used as the substrate (data not shown).  However, in 
experiments where we tested multiple acyl-CoAs, it was necessary to keep the concentration of MgCl2 at 4 
mM for both Nudt7 and Nudt19 to prevent the precipitation of lauroyl- and steroyl-CoA.  Under these 
conditions, the specific activity per pmole of Nudt19 was lower than that of Nudt7, but the enzyme readily 
hydrolyzed short and medium chain acyl-CoAs, malonyl- and succinyl-CoA, in addition to free CoA (Fig. 
2.1A).  Exceptions were acetyl-CoA and the synthetic monobromobimane (mBB)-CoA, which were 
excellent substrates for Nudt7, but not for Nudt19.  Nudt19 also had no detectable hydrolytic activity against 
ATP, ADP, NAD+ NADH, NADP+, and NADPH (data not shown), confirming the specificity of this 
enzyme for CoA (16).   
The mRNA levels of Nudt19 are highly abundant in mouse kidneys (16,36).  To examine the 
distribution of this protein in mouse tissues, we generated a polyclonal antibody against the full-length 
mouse Nudt19.  Consistent with the mRNA expression pattern, Nudt19 protein showed the highest 
abundance in the kidneys, with lower but still detectable levels in skeletal muscle and brain (Fig. 2.1C).  
This expression pattern was strikingly different from Nudt7, which was expressed at the highest levels in 
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the liver and, to a significantly lower extent, in white and brown adipose tissue (Fig. 2.1C).  The high 
expression level of Nudt19, combined with the minimally detectable Nudt7 protein in the kidneys (Fig. 
2.1C), suggested that Nudt19 was the major of the two isoforms in these organs.  
To determine whether Nudt19 regulated CoA levels in vivo, we obtained Nudt19+/- mice from the 
KOMP repository and bred them to generate Nudt19-/- mice and wild type littermate controls.  The Nudt19-
/- mice were viable, fertile and outwardly normal.  Successful deletion of the gene was verified by PCR 
analysis of tail biopsies (Fig. 2.2A), while western blot analysis confirmed the lack of Nudt19 protein 
expression (Fig. 2.2B).  Additionally, enzymatic assays confirmed the lack of any residual formation of 
3’,5’-ADP in kidney homogenates obtained from Nudt19-/- mice (Fig. 2.2C).  The concentration of CoA 
was measured in the kidneys of Nudt19-/- and control mice in the fed state and following an overnight fast.  
In the fed state, the kidneys of the Nudt19-/- mice exhibited a significant 20% increase in the concentration 
of CoA compared to the wild type mice (Fig. 2.2D).  Fasting induced an increase in kidney CoA levels in 
both wild type and Nudt19-/- mice.  Under these conditions, the concentration of CoA in the Nudt19-/- 
kidneys tended to be higher than control mice, but the difference did not reach statistical significance.  No 
compensatory increase in Nudt7 transcript levels was detected in the kidneys of the Nudt19-/- mice in either 
the fed or fasted states (Fig. 2.2E).  Combined, these data showed that Nudt19 was the major CoA 
diphosphohydrolase in the kidneys and that this enzyme contributed to the regulation of kidney CoA levels 
in vivo.   
Mouse Nudt7 and other CoA diphosphohydrolases from S. cerevisiae and C. elegans localize to 
the peroxisomes (17,22,37), which suggests that these enzymes might specifically regulate the peroxisomal 
pool of CoA (38,39).  Nudt19 contains a C-terminal peroxisome targeting signal type 1 (PTS1), Ala-His-
Leu, and was originally identified as a peroxisomal enzyme by the proteomic analysis of kidney 
peroxisomes (16).  Recently, proteomic studies conducted on isolated mitochondria have also led to the 
annotation of Nudt19 as a mitochondrial enzyme in the Mitocarta2.0 inventory (29).  Given the common 
contamination of isolated peroxisomes and mitochondria with variable amounts of other organelles, we 
used immunofluorescence and confocal microscopy to determine the intracellular localization of Nudt19 in 
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whole HEK 293 cells (Fig. 2.3).  HEK 293 cells were transiently transfected with constructs expressing 
Nudt19 with N- or C-terminal GFP tags. Nuclei were stained with DAPI, mitochondria with Mitotracker 
Orange CMTMRos, and peroxisomes were visualized with an antibody against the endogenous 
peroxisomal protein PMP70.  When expressed with an N-terminal GFP tag that left the PTS1 exposed, 
Nudt19 co-localized with PMP70, as shown by the yellow pixels resulting from the overlap of the green 
and red contributions (Fig. 2.3A-C).  Masking the PTS1 of Nudt19 with a C-terminal GFP tag prevented 
the peroxisomal localization (Fig. 2.3G-I) but did not direct the protein to the mitochondria (Fig. 2.3J-L), 
leading instead to a diffuse cytoplasmic localization.  Overall, these results supported the conclusion that 
Nudt19 was a peroxisomal enzyme.  As such, the 20% increase measured in the whole kidney homogenates 
from fed Nudt19-/- mice (Fig. 2.2D) could be an underestimation of the local accumulation of CoA in the 
kidney peroxisomes of these animals. 
Nudt19, but not Nudt7, is Competitively Inhibited by Specific Bile Acids 
Deletion of Nudt19 led to a significant increase in kidney CoA levels in fed but not fasted mice 
(Fig. 2.2D).  This suggested that, in a wild type mouse, the activity of Nudt19 might be higher in the fed 
state compared to the fasted state.  We analyzed Nudt19 mRNA and protein expression levels in the kidneys 
of mice fed ad libitum and mice fasted for up to 48h, but we did not detect any difference (Fig. 2.4A-C).  
We then focused our attention on metabolite regulation.   
We screened a panel of 30 compounds, including a large number of substrates and products of 
peroxisomal metabolism, for their effect on the activity of recombinant Nudt19 (Table 2.1).  None of the 
compounds tested significantly stimulated Nudt19 activity.  Instead, we found that a select group of bile 
acids inhibited the enzyme by >50%.  More specifically, chenodeoxycholic acid (CDCA) and its conjugated 
derivatives, taurochenodeoxycholic acid and glycochenodeoxycholic acid, decreased Nudt19 activity by 
60-75% with respect to vehicle control (Table 2.1).  More hydrophobic bile acids, such as lithocholic acid 
and ursocholanic acid, were also potent inhibitors of Nudt19 and α-muricholic acid, which derives from 
CDCA by the addition of a 6β-hydroxyl group, still retained significant potency against the enzyme.  In 
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contrast, cholic acid and its glycine and taurine conjugates exhibited decreased potency against Nudt19 
compared to CDCA.  Furthermore, other steroid compounds, such as progesterone, pregnenolone and 
corticosterone, had no significant effect on the activity of the enzyme, confirming the specificity of the 
inhibitory effect of CDCA and derived bile acids on Nudt19 (Table 2.1).   
Interestingly, none of the compounds tested, including CDCA, significantly affected the activity of 
Nudt7 (Table 1).  In addition, isothermal titration calorimetry (ITC) studies showed no detectable binding 
of CDCA to the liver enzyme, while the Kd of the Nudt19-CDCA complex was determined to be 8.3 µM 
(ΔG = -6.9 kcal/mol) (Fig. 2.5A and B).  Further kinetic analysis of the mechanism of Nudt19 inhibition 
revealed that CDCA was a competitive inhibitor with respect to free CoA (Fig. 2.5C).  Combined, these 
results identified CDCA as a specific competitive inhibitor of Nudt19 in vitro. 
The CoA Boxes and the Nudix Signature Sequences of Nudt19 and Nudt7 are not Interchangeable 
Bile acids are primarily synthesized and conjugated in the liver.  While the potential relevance of 
Nudt19 inhibition by a select group of these compounds in vivo is currently not known, the lack of CDCA 
binding to Nudt7 and the competitive nature of the CDCA inhibition of Nudt19 strongly suggested that the 
CoA binding sites of the two enzymes might be different.  Nudix hydrolases that degrade CoA contain a 
conserved motif, (L/M)(L/F)TXR(S/A)[3X](R/K)[3X]G[3X]FPGG, here referred to as the CoA box, which 
is proposed to play a role in CoA binding (24) (Fig. 2.6A).  Based on the structures of both human NUDT7 
and the D. radiodurans homolog, the CoA box comprises the three β strands β2, β3 and β4, while the Nudix 
signature sequence, G1N[5X]E7N[7X]R15NE16NXXE19NE20NXG22NU, here referred to as the Nudix box, forms 
a β-strand-loop/helix/loop structural motif (Fig. 2.6A) (21,40,41).  In several validated CoA 
diphosphohydrolases, the Nudix box exhibits a variable number of 'X' residues between E7N and R15N.  The 
most extreme case is represented by mouse and human Nudt19, which contain a 45-49 amino acid insertion 
(Fig. 2.6A).  Given its position within the Nudix box, this insertion would occur between strand β4 and 
helix α2, i.e. in the first loop of the Nudix β-strand-loop/helix/loop structural motif (Fig. 2.6A).    
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We swapped the CoA box in Nudt7 and Nudt19, generating a chimeric Nudt7 with the Nudt19 CoA 
box, Nudt7-19-CB, and a chimeric Nudt19 with the Nudt7 CoA box, Nudt19-7-CB.  We also substituted 
the Nudix box of Nudt7 with that of Nudt19 producing a Nudt7-19-NB chimera.  All three chimeras were 
expressed and purified in amounts similar or higher compared to the wild type Nudt7 and Nudt19.  
Conversely, exchanging the Nudix box in Nudt19 with the shorter Nudt7 Nudix box produced a protein 
that could be expressed but not purified as a soluble enzyme.  Interestingly, a similar result was obtained 
when we expressed a Nudt19(∆58-103) mutant lacking the unique insertion sequence in the Nudix box 
(data not shown), suggesting that this amino acid stretch could be important for the folding and/or stability 
of Nudt19.  The three soluble chimeras were analyzed by analytical gel filtration to assess their folding.  
Based on their calculated molecular weight, about 70% of Nudt19-7-CB and Nudt7-19-CB eluted as 
globular monomers, similar to wild type Nudt7 and Nudt19 (Fig. 2.6B).  Smaller peaks, indicating the 
formation of multimers, were also detected in both the chimeras and the wild type enzymes (Fig. 2.6B).  
Despite evidence of protein folding, the specific activities of Nudt19-7-CB, Nudt7-19-CB and Nudt7-19-
NB were decreased 2-3 orders of magnitude compared to the respective wild type enzymes (Fig. 2.6C).  In 
particular, the substitution of the CoA box of Nudt19 with that of Nudt7 caused >5,000-fold decrease in the 
kcat and a 3-fold increase in the KM for free CoA compared to Nudt19 (Table 2.2).  Similarly, swapping the 
Nudt7 CoA box with the CoA box of Nudt19 in Nudt7-19-CB led to a 500-fold decrease in kcat and a 5-fold 
increase in KM.  Finally, exchanging the Nudix box in Nudt7-19-NB caused a 200-fold decrease in kcat and 
a 3-fold increase in KM compared to Nudt7 (Table 2.2).   
Wild type Nudt19 and Nudt7 readily degrade free CoA and lauroyl-CoA but exhibit different 
activities against acetyl-CoA and mBB-CoA, which are good substrates for Nudt7 but not Nudt19 (Fig. 
2.1A and 1B).  We next determined the effect of swapping the Nudix and CoA boxes on the substrate 
specificity of the three soluble chimeras Nudt19-7-CB, Nudt7-19-CB and Nudt7-19-NB (Fig.  2.6D).  For 
each enzyme, the activity data with the different substrates were plotted relative to free CoA to allow for 
comparison across enzymes with dramatically different specific activities.  All three proteins, including the 
Nudt19 chimera Nudt19-7-CB, degraded acetyl-CoA and mBB-CoA, with a significantly higher relative 
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preference for the latter substrate compared to wild type Nudt7 and Nudt19.  Combined with the dramatic 
reduction in kcat and robust decrease in KM (Table 2.2), the altered substrate specificity of the chimeras 
suggested that swapping the Nudix and CoA boxes between Nudt19 and Nudt7 might have caused a 
substantial deformation of the respective active sites.   
Mutagenesis-guided Modeling of Nudt19 
The recently released crystal structure of human NUDT7 is the only currently available structure 
of a mammalian CoA diphosphohydrolase.  This structure does not contain any divalent cation, essential to 
correctly orient the diphosphate bond of the substrate for hydrolysis, or CoA bound (23).  To identify 
Nudt19 residues involved in CoA and possibly CDCA binding, we decided to build a model of the putative 
structure of Nudt19 in complex with Mg2+ and free CoA using a computational approach guided by 
mutational analysis.   
Within the Nudix box, the carbonyl group of G1N and two of the three glutamates in the E16N, E19N 
and E20N series, participate in the coordination of the essential divalent cation (24,40-45).  E16N, E19N and 
E20N correspond to E112, 115 and 116 in Nudt19, respectively (Fig. 2.6A and 2.7C).  Mutation of these 
residues to alanine abolished the enzymatic activity of Nudt19 E112A and Nudt19 E116A (Table 2.2).  The 
activity of Nudt19 E115A was detectable; however, the enzyme exhibited a ∼2000-fold decrease in kcat and 
a 3-fold increase in KM (Table 2.2).  Interestingly, the effect of this mutation on the KM suggested that this 
residue of the Nudix box contributed to CoA binding.  We also mutated the equivalent Nudt7 residues E1692, 
E1995 and E2096. Similar to the Nudt19 mutants, Nudt7 E92A and Nudt7 E96A did not show any detectable 
activity.  Mutation of Nudt7 E95 to alanine decreased the kcat >10-fold but, unlike the equivalent mutant in 
Nudt19, it had no significant effect on the KM for CoA.  Overall, these results were consistent with 
mutagenesis studies conducted on other Nudix hydrolases (42,46,47), and confirmed the importance of 
E16N, E19N and E20N for the activity of both Nudt19 and Nudt7.  The crystal structure of the CoA 
diphosphohydrolase from D. radiodurans, CoAse, contains Mg2+ bound (24).  Although unable to fit 
completely, docking of free CoA onto the 'closed' structure of the bacterial CoAse suggested the existence 
of a potential contact between the side chain of R55, the first arginine in the CoA box (Fig. 2.6A), and the 
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diphosphate bond of CoA (24).  Additionally, mutation of the equivalent residue to a glutamine in the A. 
thaliana homolog AtCoAse led to a dramatic decrease in activity (48).  This arginine residue is highly 
conserved across CoA diphosphohydrolases, and corresponds to R34 in Nudt19 and R60 in Nudt7 (Fig. 
2.6A).  Mutation of these residues to a methionine, an amino acid with a comparable side chain but no 
charge, dramatically decreased the kcat of the Nudt19 R34M and Nudt7 R60M mutants by 200 and 2000-
fold, respectively, and caused a 2-3 fold increase in the KM.  Combined, these data supported the importance 
of this residue for catalysis.   
We used this information as a guide to evaluate computational models of Nudt19 generated by 
using the YASARA modeling software suite (32).  Specifically, the final model that we selected exhibited 
1) the correct positioning of E16112, E19155 and E20116 with respect to Mg2+, 2) the appropriate orientation of 
the diphosphate moiety of free CoA with respect to Mg2+ to allow for catalysis, and 3) interaction of R34 
with the diphosphate group of the substrate CoA (Fig. 2.7B-C).  In this model, the CoA and Nudix boxes 
of Nudt19 folded into the expected structural motifs with very good superposition with the CoA and Nudix 
boxes of the D. radiodurans CoAse and human NUDT7 (Fig. 2.7A).  Within the β-strand-loop/helix/loop 
structural motif of the Nudix box, the 45 amino acid insertion in Nudt19 was modeled as an expansion in 
the loop connecting the strand β4 to the helix α2 and was mostly unstructured.   
Identification of Additional Residues Involved in CoA Binding and Hydrolysis 
Based on the model, we selected and mutated a set of Nudt19 residues predicted to participate in 
the binding of CoA (Table 2.2).  In particular, we mutated R39, F40, L41, which are part of the CoA box, 
and R189 to alanine (Fig. 2.6A and 2.7C).  In the Nudt19 model, the side chains of F40 and L41 extended 
towards the free thiol end of the CoA molecule, while the side chain of R39 extended towards the 3'-
phosphate of the CoA adenine ring (Fig. 2.7C).  Mutation of F40 and L41 to alanine caused a robust 3- to 
4-fold increase in the KM, confirming that these residues played a role in CoA binding.  In addition, the 
Nudt19 L41A mutant also showed a ∼ 3-fold decrease in kcat.  Mutation of R39 to an alanine did not have 
a significant effect (<2-fold) on the KM; however, removal of the positive charge caused a 3-fold decrease 
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in kcat, indicating that this residue was nevertheless important for CoA hydrolysis.  R189 was located in a 
loop region outside the CoA box and stretched towards the adenosine moiety of CoA (Fig. 2.7C).  The 
Nudt19 R189A mutant exhibited a 3-fold increase in KM and a 2-fold decrease in kcat, confirming that R189 
was important for both CoA binding and hydrolysis.  We further investigated the role of this residue by 
mutating R189 to a methionine.  Unlike alanine, the side chain of methionine was able to functionally 
replace R189, thus suggesting the existence of potential non-polar side chain interaction(s) between R189 
and CoA (Table 2.2).  Since Nudt19 R34M, F40A, L41A and R189A mutants exhibited a reduced affinity 
for CoA (Table 2.2), we tested the sensitivity of these mutants to inhibition by the competitive inhibitor 
CDCA (Fig. 2.5C).  At a concentration of 250 µM of free CoA, the IC50 of CDCA was determined to be 
125 µM against wild type Nudt19.  Among the above mutants, Nudt19 R34M retained ∼80% of activity in 
the presence of CDCA (Fig. 2.7D), suggesting that R34 might be involved in both CoA and CDCA binding.   
Although one of the variable 'X' residues in the Nudix box, Nudt19 D53 is highly conserved among 
the CoA diphosphohydrolases (Fig. 2.6A).  In the Nudt19 model, this residue showed no interaction with 
CoA, but we nevertheless mutated it to alanine to determine the effect of the mutation on KM and kcat.  
Consistent with the model, the Nudt19 D53A mutant exhibited kinetic parameters similar to the wild type 
enzyme, and we obtained similar results with the equivalent Nudt7 D79A mutant (Table 2.2).  The sequence 
alignment of the CoA diphosphohydrolases also showed that it was common to find a positively charged 
residue in the same position as Nudt19 R39, a residue involved in catalysis but not CoA binding (Table 
2.2).  We mutated the equivalent residue in Nudt7, K65, to alanine.  The Nudt7 K65A mutant exhibited a 
∼3-fold increase in both KM and kcat, showing a differential effect on both kinetic parameters with respect 
to Nudt19.  Finally, since F40 in Nudt19 was involved in substrate binding, we mutated the equivalent 
Nudt7 R66 to both alanine and methionine.  Nudt7 R66A showed a >10-fold increase in KM, with only a 
minor effect on kcat.  Conversely, the Nudt7 R66M mutant exhibited kinetic parameters similar to the wild 
type enzyme (Table 2.2).  These results supported the conclusion that the side chain of R66 participated in 
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CoA binding through hydrophobic interactions, and suggested that F40 in Nudt19 and R66 in Nudt7 might 
be functionally similar.   
Discussion 
To gain insight into the physiological role of Nudt19, a Nudix enzyme with CoA 
diphosphohydrolase activity, one the major goals of this study was to determine the ability of the enzyme 
to regulate CoA levels in vivo.  The present work demonstrates that Nudt19 degrades CoA and contributes 
to the regulation of this cofactor in the kidneys.  Indeed, Nudt19-/- mice exhibited a significant 20% increase 
in total CoA levels in whole kidney homogenates obtained from fed mice (Fig. 2.2D).  This result is 
consistent with the very narrow tissue distribution of the protein, which showed the highest expression 
levels in the kidneys, with brain and skeletal muscle containing barely detectable levels of Nudt19 (Fig. 
2.1C).   
The second goal of this study was to address conflicting reports on the peroxisomal and 
mitochondrial localization of Nudt19, as peroxisomes and mitochondria contain separate pools of CoA and 
are the sites of distinct CoA-dependent metabolic processes (7,49).  Using immunofluorescence and 
constructs expressing Nudt19 with either a C-terminal or an N-terminal GFP tag, we showed that the 
enzyme resides in the peroxisomes and not in the mitochondria (Fig. 2.3), thus suggesting a specific role 
for Nudt19 in peroxisomal metabolism.  In the peroxisomes, free CoA and acyl-CoAs are imported through 
dedicated transporters (50,51) and participate in several processes including the α- and β-oxidation of fatty 
acids that are not substrates for the mitochondrial oxidative machinery, the synthesis of ether phospholipids 
and, in the liver, the final steps in bile acid synthesis and conjugation.  Additionally, since imported CoA 
species and other molecules >400 Da cannot freely exit the peroxisomes, the Nudix-mediated hydrolysis of 
CoA species to 3',5'-ADP and 4’-(acyl)phosphopantetheine likely prevents CoA buildup in this organelle 
(38,39).  Indeed, it has been proposed that the function of peroxisomal CoA-degrading enzymes, including 
Nudt7 and now Nudt19, is to regulate the peroxisomal CoA pool and, in turn, peroxisomal lipid metabolism 
(38).  Consistent with this proposed role, Nudt19 activity was highest with free CoA, which is required in 
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multiple peroxisomal pathways, and with succinyl-CoA and C8-C12 acyl-CoAs, which are the oxidation 
products of dicarboxylic and very long-chain fatty acids, respectively (Fig 2.1A).  Nudt19 was previously 
reported to possess mRNA decapping activity in vitro (28).  Although detectable, the hydrolytic activity of 
Nudt19 against capped RNA was minimal when compared to that of established mRNA decapping enzymes 
such as Dcp2 and Nudt16 (28).  Additionally, mRNA decapping occurs in cytosolic foci (52).  Thus, the 
peroxisomal localization of Nudt19, combined with its effect on CoA levels in vivo, argues against a role 
for this enzyme in mRNA decapping.   
The peroxisomal localization of Nudt19 and fact that the enzyme could affect just one of the 
subcellular CoA pools could also explain the relatively small increase in total CoA levels observed in whole 
kidney homogenates obtained from Nudt19-/- mice in the fed state.  In the fasted state, the concentration of 
kidney CoA was higher than in the fed state and similar between wild type control and Nudt19-/- mice.  
These results suggest that the increase in kidney CoA levels that occurs upon fasting may be promoted 
more by activation of the CoA biosynthetic pathway than by a decrease in CoA degradation.  The flux 
through the CoA biosynthetic pathway is controlled by the pantothenate kinase (PanK) isoforms, and 
PanK1, which is the isoform that drives the increase in CoA levels observed in the liver of fasted mice, is 
also the major PanK isoform in the kidneys (13,53).  Upon refeeding, a net decrease in CoA levels requires 
not only inhibition of CoA synthesis, but also active degradation of the cofactor accumulated in the fasted 
state.  This might explain why the effect of deleting Nudt19 on kidney CoA levels was mostly detected in 
fed mice.  Interestingly, although the Nudt19-/- mice exhibited higher kidney CoA levels in the fed state 
compared to control mice, this concentration of the cofactor was still significantly lower than in the fasted 
state, suggesting the existence of residual CoA-degrading activity in the absence of Nudt19.  Nudt7 and 
Nudt19 are the only currently confirmed CoA-degrading enzymes and, in the kidneys, Nudt7 is a minor 
isoform (Fig. 2.1C, and compare 2.2E to 2.4A).  Under our experimental conditions, the production of 3',5'-
ADP in kidney extracts from Nudt19-/- mice was undetectable (Fig. 2.2C), and we did not observe any 
compensatory upregulation of Nudt7 (Fig. 2.2E).  In spite of this, an accurate estimate of the contribution 
of Nudt7, if any, to the regulation of kidney CoA levels, will require the generation of mice with a deletion 
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in both Nudt7 and Nudt19.  Alternatively, CoA might be hydrolyzed to products other than 3',5'-ADP and 
4’-(acyl)phosphopantetheine by a novel class of CoA-degrading enzymes that may or may not reside in the 
peroxisomes.   
The narrow and non-overlapping tissue distribution of Nudt19 and Nudt7 in kidneys and liver, 
respectively, is intriguing.  Another major goal of this study was to investigate the distinctive biochemical 
and regulatory properties of these enzymes to gain insight into the physiological roles that Nudt19 and 
Nudt7 may play in their respective organs.  Nudt19 (42 kDa) is significantly larger than Nudt7 (27 kDa), 
and contains unique sequence regions, the most notable of which is the 45 amino acid insertion in the Nudix 
box, which are not present in Nudt7 (Fig. 2.6A).  Nudt7 expression in the liver decreases in the fasted state 
and increases in the fed state, showing an inverse correlated with the hepatic concentration of CoA (9,26).  
Conversely, Nudt19 mRNA and protein levels in the kidneys did not change between the fed and fasted 
states, in spite of the fact that this enzyme contributes to the regulation of kidney CoA levels.   
While searching for potential small molecule regulators, we identified CDCA as a competitive 
inhibitor of Nudt19 that did not bind to Nudt7, strongly suggesting that these two enzymes possess distinct 
CoA binding sites (Fig. 2.5).  Interestingly, binding of CDCA to Nudt19 depended, at least in part, on R34 
(R60 in Nudt7), a highly conserved residue involved in CoA binding and hydrolysis in both Nudt19 and 
Nudt7 (Fig. 2.6A, 2.7D and Table 2.2).  Additional evidence in support of a different organization of the 
CoA binding sites between the two isoforms is provided by the different activities that Nudt19 and Nudt7 
displayed against substrates such as acetyl-CoA and mBB-CoA and by the dramatic decrease in kcat 
observed upon exchange of the CoA and Nudix boxes between the two enzymes.  Furthermore, the invariant 
E19N in the Nudix box was found to participate in CoA binding in Nudt19 but not Nudt7, while the conserved 
(R/K) residue in the CoA box (corresponding to K65 in Nudt7 and R39 in Nudt19) was found to be involved 
in CoA binding in Nudt7 but not Nudt19.   
No structural information on CoA diphosphohydrolases with CoA bound is currently available and 
this represents a limitation to the accurate prediction of the mode of CoA binding through homology 
models.  In spite of this, mutational analysis based on the Nudt19 model that we generated allowed us to 
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identify residues that are important for CoA binding and hydrolysis (Table 2.2).  These residues were found 
both within and outside the CoA box.  The Nudt19 model also shows that the 45 amino acid insertion within 
the Nudix box may be mostly disordered.  Within a protein, disordered regions can exert different functions, 
including providing display sites for post-translational modification and/or mediating protein-protein 
interactions (54).  There are only a few known examples of peroxisomal proteins regulated through 
reversible post-translational modifications (55,56), and the role of this potentially disordered sequence, if 
any, in the regulation Nudt19 activity remains to be elucidated.  We also docked Mg2+ and free CoA to the 
NUDT7 crystal structure to determine whether we could find a pose that would agree with the mutational 
analysis on the closely related mouse Nudt7, and provide us with a model of CoA binding to NUDT7.  As 
for Nudt19, we selected the most likely models using the position of E1692, E1995, E2096, R60, CoA and Mg2+. 
In these models, R66 (equivalent to R66 in mouse Nudt7) would form a salt bridge with the diphosphate 
moiety of CoA (data not shown).  While the 10-fold increase in KM of the Nudt7 R66A mutant supports the 
importance of R66 for substrate binding, the lack of effect of the R66M mutation on the kinetic parameters 
of the enzyme indicates that the requirement for R66 is likely spatial and geometric and not about the charge 
(Table 2.2).  Thus, in this case, the docking of CoA to the structure of NUDT7 does not seem to provide a 
close representation of how CoA binds to this enzyme.  Crystallization of NUDT7 and possibly Nudt19 
with a substrate bound will be required to yield further details of CoA binding. 
Finally, bile acids are synthesized de novo exclusively in the liver, with the last steps in the 
synthesis and conjugation to glycine and taurine occurring in the peroxisomes (57).  While it may be 
unlikely for Nudt19 to encounter high concentrations of CDCA in kidney peroxisomes, Nudt7 is 
presumably exposed to high concentrations of CDCA, cholic acid, and conjugated derivatives in liver 
peroxisomes.  Thus, it is tempting to speculate that the ability of Nudt7 to remain active even at high 
micromolar concentrations of bile acids, is one possible reason for the selection of this enzyme as the major 
CoA diphosphohydrolase in the liver.  As for Nudt19, further studies, including an in depth characterization 
of the Nudt19-/- mice, will be required to determine what selective advantage(s) this isoform may confer to 
the kidneys. 
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Table and figure legends 
Table 2.1. Effect of selected metabolites on the activity of Nudt19 and Nudt7. Nudt19 and Nudt7 were 
assayed in the presence of 250 µM of each compound, unless otherwise indicated, and free CoA as 
substrate. A '-' sign indicates a decrease in activity with respect to the vehicle control.  A '+' sign indicates 
an increase in activity with respect to the vehicle control.  Metabolites that decreased or increased the 
activity ≥50% are shaded in gray.   
Table 2.2. Kinetic parameters of Nudt19 and Nudt7 mutants and chimeras. Experiments were 
conducted in duplicate as described in 'Experimental Procedures'.  Kinetic constants were determined by 
non-linear regression analysis of the data and expressed ± the standard error. ND indicates that the 
parameters were not determined due to undetectable enzymatic activity.   
Figure 2.1. In vitro activity and tissue distribution of Nudt19 and Nudt7. Recombinant mouse Nudt19 
(A) and Nudt7 (B) were incubated with 250 µM of each CoA substrate, and the 3',5'-ADP produced was 
quantified as described in the "Experimental Procedures' section.  Data are plotted as the mean (bars) of 
duplicate measurements from 2-3 independent experiments (circles) ± standard deviation.  (C) Immunoblot 
analysis to detect Nudt19 and Nudt7 proteins in mouse tissues.  Tissue lysate proteins (150 µg) were 
fractionated by SDS-PAGE, transferred to a PVDF membrane and blotted with the Nudt19 antibody.  The 
same membrane was then stripped and blotted with antibodies against GAPDH (loading control) and Nudt7.  
Note that although the same amount of protein was loaded, different tissues contain a different amount of 
GAPDH.  Abbreviations are: Panc., pancreas; WAT, white adipose tissue; BAT, brown adipose tissue; NS, 
non-specific band. 
Figure 2.2. Effect of Nudt19 deletion on kidney CoA levels. Mouse genotyping.  Multiplex PCR reactions 
were set up to detect the wild type and/or the knockout allele, as described in the 'Experimental Procedures' 
section.  A PCR product of 185 bp indicated a wild type allele; a PCR product of 466 bp indicated a 
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knockout allele.  Heterozygous mice exhibited both bands. M, marker; WT, wild type; Hz, heterozygous; 
KO, knockout.  (B) Western blot analysis of kidney homogenates (150 µg) from wild type and Nudt19-/- 
mice using the Nudt19 antibody.  GAPDH was used as a loading control.  NS, nonspecific band.  (C) 
Production of 3',5'-ADP in reaction mixtures containing free CoA and kidney extracts from wild type and 
Nudt19-/- mice.  Numbers in parenthesis represent the number of animals analyzed; data are reported as the 
mean ± standard deviation.  (D) Total CoA measured in the kidneys of wild type and Nudt19-/- mice fed ad 
libitum or fasted overnight (ON).  (E) Nudt7 mRNA abundance in the kidneys of fed and fasted wild type 
and Nudt19-/- mice.  Data in (D) and (E) are reported as the mean (bars) of measurements on individual 
mice (circles and squares) ± standard deviation. **, p<0.01 relative to wild type mice; #, p<0.05, ##, p<0.01, 
###, p <0.001 relative to the fed state.   
Figure 2.3. Localization of Nudt19 to the peroxisomes. HEK 293 cells were transfected with expression 
plasmids encoding for GFP fused to (A-F) the N-terminus (Nudt19-N-GFP) or (G-L) the C-terminus of 
Nudt19 (Nudt19-C-GFP).  Fixed cells were visualized using confocal microscopy.  (B, C, H, I) The 
endogenous PMP70 protein was used as a marker for the peroxisomes, shown in red.  (E, F, K, L) 
Mitochondria were visualized using Mitotracker Orange CMTMRos and shown in red.  (A-L) Cell nuclei 
were stained with DAPI, in blue.  (C, F, I, L) Insets in merged images show details at higher magnification.  
The results are representative of at least 2 independent experiments. 
Figure 2.4. Nudt19 expression in the kidneys of fed and fasted mice. (A) Nudt19 transcript levels in the 
kidneys of fed, overnight fasted (ON), and 48h fasted mice.  (B) Western blot analysis showing that Nudt19 
protein levels in the kidneys did not change between fed, overnight fasted, and 48h fasted mice.  α-Tubulin 
was used as a loading control.  (C) Quantification of the western blot in (B).  Data are reported as the mean 
(bars) of measurements on individual mice (circles, squares and diamonds) ± standard deviation.   
Figure 2.5. CDCA binds to Nudt19 but not to Nudt7.  ITC binding curves of (A) Nudt19 and (B) Nudt7.  
The binding curves are representative of 2-3 independent experiments.  (C) Graphical analysis of CDCA 
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inhibition of Nudt19 using fixed concentrations of the inhibitor and variable concentrations of free CoA 
revealed that CDCA was competitive with free CoA.  Data are reported as the mean of 2 independent 
experiments, in duplicate, ± standard deviation.   
Figure 2.6. Effect of exchanging the CoA and Nudix boxes of Nudt19 and Nudt7. (A) Alignment of the 
CoA and Nudix boxes of characterized CoA diphosphohydrolases from different organisms.  Invariant 
residues are highlighted in red, conserved residues in yellow, and groups of conserved residues are boxed.  
The Nudix and the CoA boxes overlap at a glycine highlighted in black.  Residues mutated in both Nudt19 
and Nudt7 are marked with a blue star.  Residues mutated just in Nudt19 are marked with a blue open circle.  
Secondary structure elements of the Deinococcus radiodurans CoAse (Dr1184, PDB ID: 1NQZ) and 
human NUDT7 (HsNUDT7, PDB ID: 5T3P) are shown on top of the alignment.  The unique insertion 
sequence found in mouse and human Nudt19 would be inserted (blue triangle) in the loop region between 
the β strand and the α helix of the Nudix box structural motif.  Mm, Mus musculus; Hs, Homo sapiens; Dr, 
Deinococcus radiodurans; Sc, Saccharomyces cerevisiae; Ce, Caenorhabditis elegans. Genbank GI 
numbers for the aligned proteins are as follows: MmNudt7,165972342; HsNUDT77, 157785656; 
MmNudt19, 187954021; HsNUDT19, 157739940; Dr1184, 6458920; ScPcd1p, 6323180; CeNdx8, 
68565843.  (B) Calibration curve of the Superdex 75 10/300 GL column and elution profile of wild type 
Nudt19, Nudt7 and chimeras.  The native molecular weights of the protein peaks, as estimated from the 
calibration curve, are reported for each enzyme.  The calculated molecular weights of the recombinant His-
tagged proteins, based on the amino acid composition, are: wild type Nudt19, 42.6 kDa; Nudt19-7-CB, 42.6 
kDa; wild type Nudt7, 29.2 kDa; Nudt7-19-NB, 34.0 kDa; Nudt7-19-CB, 29.1 kDa.  (C) Specific activity 
of the recombinant Nudt19, Nudt7, and chimeric proteins.  Specific activities ± standard error were 
calculated from the linear regression of 5-point protein curves obtained for each enzyme from at least 2 
independent experiments in duplicate.  (D) Substrate specificity of Nudt19, Nudt7, and chimeric proteins. 
Activity with each CoA species is expressed as percentage relative to the activity with free CoA.  Data are 
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reported as the mean (bars) of duplicate measurements from 2-3 independent experiments (circles) ± 
standard deviation.  NB, Nudix box; CB, CoA box.   
Figure 2.7. Homology model of Nudt19 with magnesium ion and free CoA bound. (A) Alignment of 
the CoA and Nudix box regions of the Nudt19 model (cyan) with the crystal structures of human NUDT7 
(magenta, PDB ID: 5T3P) and D. radiourans CoAse (grey, PDB ID: 1NQZ).  (B) The homology model for 
Nudt19 with Mg2+ bound (orange sphere) was obtained using the YASARA modeling software suite.  Free 
CoA (sticks) was then docked using MOE and the resultant complex evaluated and selected as described in 
the text.  Structural elements in the CoA and Nudix boxes are shown in green and cyan, respectively.  The 
unique amino acid insertion in the Nudix box of Nudt19 is shown as a red dotted line in both (A) and (B).  
(C) Mode of CoA binding to Nudt19, with potentially interacting residues shown.  (D) Activity of Nudt19 
mutants incubated with or without the competitive inhibitor CDCA.  Data are reported as the mean (bars) 
of duplicate measurements from 2-3 independent experiments (circles) ± standard deviation. 
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Tables and figures 
Table 2.1. Effect of selected metabolites on the activity of Nudt19 and Nudt7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Metabolite 
% Activity relative to 
vehicle 
Nudt19 Nudt7 
   
Hydrogen peroxide (10 µM) +16 -11 
Hydrogen peroxide (100 µM) +3 +5 
ATP +6 +2 
NAD+ -5 +1 
NADH -13 +20 
NADP+ -16 +4 
NADPH -5 +7 
NMN -8 -1 
Pyruvate +13 -17 
α-Ketoglutarate 0 -8 
Isocitrate -9 -5 
Sarcosine +8 +4 
Carnitine -3 -1 
Glycine -4 +16 
Taurine +5 +24 
Lauric acid -16 -4 
Palmitic acid (50 µM) -2 -32 
Palmitoylcarnitine (50 µM) +23 +11 
Cholic acid -24 +8 
Glycocholic acid -30 +10 
Taurocholic acid -17 +3 
Chenodeoxycholic acid -62 +1 
Glycochenodeoxycholic acid -67 +3 
Taurochenodeoxycholic acid -75 +11 
α-Muricholic acid  -50 -8 
Lithocholic acid (50 µM)  -83 -15 
Ursocholanic acid (50 µM)  -70 +12 
Corticosterone  -26 -7 
Progesterone  -37 0 
Pregnenolone  -15 +14 
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Table 2.2. Kinetic parameters of Nudt19 and Nudt7 mutants and chimeras. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutation KM (µM) kcat (1/min) 
Nudt19 
WT 300 ± 40 284 ± 12 
Nudt19-7-CB 1134 ± 284 0.05 ± 0.01 
E112A ND ND 
E115A 1019 ± 226 0.16 ± 0.02 
E116A ND ND 
R34M 680 ± 186 0.12 ± 0.01 
R39A 511 ± 64 91 ± 4 
F40A 1053 ± 153 210 ± 12 
L41A 1250 ± 125 101 ± 4 
D53A 434 ± 59 323 ± 16 
R189A 1193 ± 184 118 ± 11 
R189M 455 ± 80 177 ± 10 
Nudt7 
WT 283 ± 94 125 ± 12 
Nudt7-19-CB 1362 ± 328 0.28 ± 0.03 
Nudt7-19-NB 836 ± 173 0.65 ± 0.04 
E92A ND ND 
E95A 444 ± 87 10 ± 0.7 
E96A ND ND 
R60M 1010 ± 155 0.55 ± 0.03 
K65A 958 ± 277 463 ± 56 
R66A 3069 ± 407 220 ± 10 
R66M 496 ± 79 167 ± 7 
D79A 334 ± 29 159 ± 5 
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Figure 2.1. In vitro activity and tissue distribution of Nudt19 and Nudt7. 
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Figure 2.2. Effect of Nudt19 deletion on kidney CoA levels.  
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Figure 2.3. Localization of Nudt19 to the peroxisomes.  
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Figure 2.4. Nudt19 expression in the kidneys of fed and fasted mice.  
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Figure 2.5. CDCA binds to Nudt19 but not to Nudt7.  
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Figure 2.6. Effect of exchanging the CoA and Nudix boxes of Nudt19 and Nudt7.  
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Figure 2.7. Homology model of Nudt19 with magnesium ion and free CoA bound.  
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Chapter III: Identification of the in vivo CoA species and subcellular CoA pool(s) regulated by 
Nudt7 
 
Shumar, S. A., Kerr, E. W., Fagone, P., Infante, A. M., & Leonardi, R. (2019). Overexpression of the 
CoA-degrading enzyme Nudt7 decreases liver bile acid levels and peroxisomal fatty acid oxidation.  
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Abstract  
Lipid metabolism requires coenzyme A (CoA), an essential cofactor found in multiple subcellular 
compartments including the peroxisomes.  In the liver, CoA levels are dynamically adjusted between the 
fed and fasted states.  Elevated CoA levels in the fasted state are driven by increased synthesis; however, 
this also correlates with decreased expression of Nudt7, the major CoA-degrading enzyme in the liver.  
Nudt7 resides in the peroxisomes and we overexpressed this enzyme in mouse livers to determine its effect 
on the size and composition of the hepatic CoA pool in the fed and fasted states.  Nudt7 overexpression did 
not change total CoA levels but decreased the concentration of short-chain acyl-CoAs and choloyl-CoA in 
fasted livers, when endogenous Nudt7 activity was lowest.  The effect on these acyl-CoAs correlated with 
a significant decrease in the hepatic bile acid content and in the rate of peroxisomal fatty acid oxidation, as 
estimated by targeted and untargeted metabolomics, combined with the measurement of fatty acid oxidation 
in intact hepatocytes.  Identification of the CoA species and metabolic pathways affected the overexpression 
on Nudt7 in vivo supports the conclusion that the nutritionally-driven modulation of Nudt7 activity could 
contribute to the regulation of the peroxisomal CoA pool and peroxisomal lipid metabolism. 
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Introduction 
The liver is a metabolically flexible organ that plays a key role in the maintenance of whole-body 
lipid and glucose homeostasis (1-3).  Several pathways, including gluconeogenesis, ketogenesis, and bile 
acid synthesis occur primarily in this organ and rely on the availability of the essential cofactor coenzyme 
A (CoA).  CoA is the major acyl group carrier in mammalian cells.  Formation of acyl-CoAs allows for the 
delivery of activated substrates for a multitude of reactions and the modulation of metabolic pathways 
through allosteric regulation or posttranslational modification of histones and key metabolic enzymes (4-
9).  Cells contain limited and regulated amounts of CoA that are sequestered in multiple subcellular 
compartments, including the cytosol, peroxisomes, mitochondria, and endoplasmic reticulum (10-13).  
Within each subcellular compartment, free CoA and acyl-CoAs support specific pathways and reactions.  
These include ketogenesis, the TCA cycle and fatty acid β-oxidation in the mitochondria, fatty acid 
synthesis in the cytosol, autophagy in the endoplasmic reticulum, and the last steps in the bile acid 
biosynthetic pathway and fatty acid α- and β-oxidation in the peroxisomes (3,12,14).   
In the liver, CoA levels change in response to the nutritional state to support the switch between 
glucose and fatty acid oxidation (11,15,16).  This dynamic modulation occurs through a balance between 
CoA synthesis and degradation, which leads to a net increase in the concentration of hepatic CoA in the 
fasted state and to a net decrease in the fed state (16-18).  CoA synthesis requires 5 enzymatic steps and is 
regulated through feedback inhibition of the first and rate-limiting enzyme of the pathway, pantothenate 
kinase, by free CoA and acyl-CoAs (19-21).  The only currently known CoA-degrading enzymes are Nudt7 
and Nudt19 (22,23).  Both enzymes are members of the Nudix hydrolase superfamily, specifically 
hydrolyze CoA species to produce 3’,5’-ADP and (acyl-)phosphopantetheine, and reside in the 
peroxisomes, organelles that play a key role in lipid metabolism (18,22-26). Nudt19 is the major isoform 
in the kidneys, where it contributes to the regulation of total CoA levels in these organs (18).  Nudt7 is the 
major CoA-degrading enzyme in the liver.  Recombinant Nudt7 hydrolyzes a broad range of CoA 
substrates, including free CoA, short- and medium-chain acyl-CoAs, and the CoA thioesters of bile acids 
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(17,18).  Unlike Nudt19, Nudt7 is not inhibited by bile acids and its expression varies with fasting and 
feeding.  In particular, Nudt7 levels decrease with fasting, correlating with the increase in CoA observed in 
fasted livers.  While these findings have established that Nudt7 can degrade CoA in vitro, it has yet to be 
determined whether Nudt7 is actively involved in regulating hepatic CoA levels in vivo.  Indeed, the 
peroxisomal CoA pool is estimated to represent only 4-10% of total liver CoA (10,11), and it is currently 
unclear to what extent the activity of Nudt7 in liver peroxisomes could affect total CoA levels in the fed 
and fasted states.  Furthermore, the localization, substrate specificity, and nutritional regulation of Nudt7 
expression suggest that this enzyme may be involved in the regulation of peroxisomal pathways (27), but 
direct evidence is lacking.   
To gain insight into the physiological role of Nudt7 and its ability to regulate liver CoA levels in 
vivo, we overexpressed the enzyme in the liver of C57BL/6J mice.  Overexpression of Nudt7 in the fasted 
state, when endogenous Nudt7 activity was lowest, did not prevent the increase in total hepatic CoA levels 
that occurs with fasting, but it changed the acyl-CoA composition of the liver by significantly decreasing 
the concentration of short-chain acyl-CoAs and choloyl-CoA, a peroxisomal intermediate in bile acid 
synthesis.  Untargeted and targeted metabolomics analysis revealed that fasted livers overexpressing Nudt7 
contained significantly reduced levels of primary and secondary bile acids, in addition to an accumulation 
of medium- and long-chain acylcarnitines, which correlated with a lower rate of peroxisomal fatty acid 
oxidation.  Our data show that overexpression of Nudt7 specifically interfered with the output of 
peroxisomal fatty acid oxidation and the bile acid biosynthetic pathway in the fasted state.  Thus, changes 
in Nudt7 activity between the fed and fasted states could act to regulate the peroxisomal CoA pool and, in 
turn, peroxisomal lipid metabolism.   
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Materials and methods 
Reagents were purchased from the following suppliers: HRP-conjugated GFP antibody, Alexa 
Fluor 647- and HRP-conjugated goat anti-rabbit IgG from Thermo Fisher Scientific; the antibodies against 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the FLAG epitope (DYKDDDK) from Cell 
Signaling; Waymouth MB 752/1 medium, medium 199 (M199) and the antibody against ATP-binding 
cassette, sub-family D, member 3 (PMP70) from Sigma-Aldrich.  The Nudt7 antibody was generated as 
previously described (15). The fluorescent CoA derivative of monobromobimane (mBB), mBB-CoA, was 
synthesized as previously described (18). All other reagents were of analytical grade or better and were 
purchased from Sigma-Aldrich or Fisher Scientific, unless otherwise stated. 
Adeno-associated virus production  
Plasmid pscAAV-LP1-EGFP, carrying the enhanced green fluorescent protein coding sequence 
(henceforth referred to as GFP), was developed by John T. Gray and provided by St. Jude Children’s 
Research Hospital, Memphis, TN.  Plasmid pscAAV-LP1-mNudt7, obtained by replacing the coding 
sequence of GFP with the sequence of mouse Nudt7 containing a FLAG tag at the N-terminus, was a kind 
gift of Suzanne Jackowski, St. Jude Children’s Research Hospital, Memphis, TN.  To produce adeno-
associated virus (AAV), HEK 293T cells were transiently transfected with a 1:1:2.5 (mass ratio) mixture 
of plasmids pHGTI-adeno1 (developed by John T. Gray and provided by Harvard College, Cambridge, 
MA), pLTAAVhelp2-8 (developed by John T. Gray and provided by St. Jude Children’s Research Hospital, 
Memphis, TN) and either pscAAV-LP1-mNudt7 or pscAAV-LP1-EGFP using polyethylenimine. 
Transfected cells were harvested 72 h post transfection and lysed in 50 mM Tris-HCl, 50 mM NaCl, 1 mM 
MgCl2, 2% Triton X-100, 50 U/ml PierceTM Universal Nuclease, pH 8.0, incubating for 20 min at 37 °C.  
The lysate was then supplemented with 0.05 volumes of sodium deoxycholate (10% solution in water) and 
further incubated at 37 °C for 10 min. Following the addition of 0.1 volumes of 5 M NaCl, the lysate was 
clarified by centrifugation at 4,000 x g for 20 min at 20 °C.  The cleared lysate was layered on top of a 
discontinuous sucrose density gradient generated by layers of 60%, 40%, 25%, and 15% sucrose in 20 mM 
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diethanolamine hydrochloride, pH 9.0.  Following centrifugation at 104,000 x g (Beckman Optima LE-80) 
for 3 h at 20 °C, the virus was recovered from the 40% sucrose layer and the 40-60% sucrose interface 
region of the gradient.  The AAV particles were further purified by ion exchange chromatography on a 
POROS 50 HQ column (ThermoFisher Scientific).  AAV elution was monitored by measuring the 
absorbance at both 260 and 280 nm.  Fractions containing the AAV particles were buffer exchanged into 
phosphate buffered saline containing 0.01% Pluronic F-68, filter-sterilized, and quantified using the agarose 
gel method previously described (28). 
Animal studies  
Mice were fed a standard chow diet (Tekland 2018S) and maintained at a room temperature of 72.0 
± 0.3 °F, room humidity of 40% ± 2%, and a 12-h light, 12-h dark cycle, with the dark cycle starting at 
18:00 h.  Six-week-old C57BL/6J male mice were purchased from Jackson Laboratory.  Following a 2-
week acclimation period, these mice were injected with 2.5*1011 genome copies of GFP- or Nudt7-AAV 
in 150 µl of sterile phosphate buffered saline and, unless otherwise indicated, were sacrificed 3-4 weeks 
after injection.  Unless otherwise stated, fasting experiments were started at 7:00 am, and mice were placed 
on cages with grids without food for the indicated amount of time.  To measure food consumption, mice 
were individually housed in cages with grids and provided with a pre-weighed amount of food.  Seventy-
two hours later, the leftover food was weighed and used to calculate the average food consumption per 
mouse per 24 h.  Serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) 
were measured using Stanbio kits (EKF Diagnostic USA) and 3-hydroxybutyrate was determined using a 
3-hydroxybutyrate enzyme solution and colorimetric detector from Cayman Chemicals, as per 
manufacturer’s instructions.  All studies were approved by the Institutional Animal Care and Use 
Committees of West Virginia University.   
CoA analysis, immunoblotting and RT-PCR 
The concentration of total CoA (free CoA plus CoA thioesters) in liver homogenates was 
determined after conversion of the cofactor to the mBB derivative, as previously described (24). For western 
blot analysis, flash frozen tissues were homogenized in ice-cold radioimmunoprecipitation assay buffer 
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supplemented with protease inhibitors (Biotool), and centrifuged at 10,000 x g for 10 min at 4 °C.  Proteins 
(5 or 20 µg) were fractionated on 4-12% bis-Tris polyacrylamide gels and transferred onto nitrocellulose 
membranes using an iBlot dry transfer system (Thermo Fisher Scientific).  The GAPDH and Nudt7 
antibodies were used at a 1:5,000 and 1:3,000 dilution, respectively.  Bound primary antibodies were 
detected by chemiluminescence with HRP-conjugated goat anti-rabbit IgG at a 1:45,000 dilution.  The 
HRP-conjugated GFP antibody was used at a 1:7,000 dilution.  RNA was isolated from flash frozen tissue 
as previously described (29).  Following the removal of genomic DNA with Turbo DNA-free kit (Thermo 
Fisher Scientific), mRNA levels were quantified in triplicate by RT-PCR using the Quantitect SYBR Green 
RT-PCR kit (Qiagen) and the primers previously reported (29).  The relative abundance of each gene was 
calculated using the CT method, and the amount (2-∆CT) reported relative to the average of ribosomal protein 
L22 (Rpl22) and β2-microglobulin (B2m).  Primers 5’-GTGCCTTTCTCCAAAAGGTATTT-3’ and 5’-
CTCTCTTTGCTGTTGGCGAC-3’ were used as forward and reverse primers, respectively, to amplify 
Rpl22.  Primers 5’-ACTGACCGGCCTGTATGCTA-3’ and 5’-ATGTTCGGCTTCCCATTCTCC-3’ were 
used as forward and reverse primers, respectively for B2m. 
RNA-Seq  
Total RNA from mouse liver tissue was isolated as described above and delivered to the WVU 
Genomics Core Facility for quality control and library preparation. The concentration of extracted total 
RNA was determined using a Qubit fluorometer (Thermo Fisher Scientific) while RNA quality was 
ascertained on an Agilent 2100 Bioanalyzer using an RNA Nano 6000 chip.  All of the samples used for 
the library preparation had RIN (RNA Integrity Number) values > 8.0.  Each library was built using 500 ng 
of RNA as input material for the stranded mRNA library preparation kit from KAPA Biosystems, following 
the manufacturer’s recommended protocol with 9 cycles of PCR.  The cDNA libraries were quantified via 
Qubit, pooled in equimolar ratios, and sent to the Genomics Core Facility at Marshall University where the 
libraries were sequenced on 4 lanes generating PE50bp reads with the Illumina HiSeq1500 system (16–
36M reads per sample, ∼175M total reads).  Read quality was assessed using FastQC 
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(https://www.bioinformatics.babraham.ac.uk/projects/fastqc) and deemed to require no trimming. The 
reads were quantified using Salmon (30) with transcripts obtained from ensemble, version GRCm38.84.  
Using tximport (31), the data was imported into R and differential expression was computed using DESeq2 
(32). We removed all genes that did not have at least a count of 10 in at least 3 samples.  Genes were 
considered to be significantly changed if the Benjamini-Hockburg adjusted p-value was less than 0.01.  
WebGestalt (http://www.webgestalt.org) was used to conduct gene ontology and pathway enrichment 
analyses.  The RNA-Seq raw data are deposited and accessible through NCBI Gene Expression Omnibus 
(https://www.ncbi.nlm.nih.gov/geo/) with the GEO Series accession number GSE125237. 
Enzymatic assays and lipid analyses 
Total liver CoA diphosphohydrolase activity was measured in liver extracts obtained by 
homogenizing flash-frozen tissue (∼20 mg) in 750 µl of 20 mM Tris-HCl pH 8.0.  The homogenates were 
incubated on ice for 10 min before centrifuging at 20,000 x g for 10 min.  The supernatants were removed 
and increasing amounts of protein (6.25-50 µg) were incubated with 100 µM of mBB-CoA for 10 min at 
37 °C.  The reactions were then stopped and analyzed as described previously (18).  
Serum cholesterol and triglycerides were measured using Stanbio kits (EKF Diagnostic USA), as 
per the manufacturer’s instructions.  Liver lipids were extracted from ∼50 mg of liver using a modification 
of the Bligh and Dyer procedure (33) optimized for lipid quantitation by the LipidMaps group (34). 
Following extraction, a portion of the lipids was dried and resuspended in 100 µl of 5% NP-40 for 
cholesterol analysis using the same Stan-Bio kit utilized for the determination of cholesterol in the serum.  
A second portion of the total lipid extract was fractionated for triglyceride analysis on HPTLC silica plates 
developed in hexane:ether:acetic acid (80:20:1, v:v:v).  Resolved lipid bands and serial dilutions of a 
tripalmitin standard were visualized and quantitated by spraying with a 0.002% primulin solution followed 
by fluorescence analysis using G:BOX Chemi XX9 imaging system (Syngene).  
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Targeted and untargeted metabolomics 
Global metabolomics profiling, combined with statistical and pathway enrichment analyses, were 
conducted by Metabolon, Inc.  Raw data and metabolite fold-changes between groups are reported in 
supplemental Table 3.S1.  Principal component analysis, normalization, and scaling of selected metabolites 
for the generation of heat plots were conducted using MetaboAnalyst 4.0 (https://www.metaboanalyst.ca/) 
(35).  Liver, small intestine, and bile samples were analyzed for their bile acid composition using a targeted 
assay by Metabolon, Inc.  For the analysis of the acyl-CoA pool composition, CoA species were extracted 
as described by Minkler P. E. et al. (36).  Briefly, flash-frozen livers (∼50 mg) were homogenized in 1.5 
ml of a 3:1 (v:v) mixture of acetonitrile:isopropanol containing 0.625 µM of heptanoyl- and heptadecanoyl-
CoA standards. Following the addition of 0.5 ml of 0.1 M KH2PO4, pH 6.7, the homogenates were 
centrifuged at 16,000 x g for 5 min.  The supernatants were acidified by the addition of 0.25 volumes of 
glacial acetic acid and applied onto 2-(2-pyridyl)ethyl-functionalized silica columns (100 mg, Sigma-
Aldrich), previously conditioned with 1 ml of a 9:3:4:4 (v:v) mixture of 
acetonitrile:isopropanol:water:acetic acid.  The columns were washed with 1 ml of the same solvent mixture 
and 1 ml of water before eluting the bound compounds with 4 ml of 90% methanol containing 15 mM 
ammonium hydroxide.  The samples were dried at room temperature under nitrogen flow and stored at -20 
°C until analyzed.  The LC/MS/MS analysis was conducted in the Metabolome Analysis Facility at West 
Virginia University on an AB Sciex QTrap 5500 mass spectrometer connected to an AB Sciex Exion UPLC 
and controlled by Analyst® Version 1.6.3 software.  Frozen extracts were re-suspended in 300 µl of 50% 
methanol and fractionated at 0.4 ml/min onto an Acquity BEH amide column (2.1 x 50 mm, 1.7 µm particle 
size, Waters) kept at 25 °C and equilibrated with 10% solvent A (50 mM ammonium formate, pH 9.5) and 
90% solvent B (acetonitrile).  Following the injection of 1.5 µl of sample, the concentration of A was 
maintained at 10% for an additional 1.5 min, followed by a linear gradient that increased the concentration 
of A to 50% in 6.5 min and then to 65% in 30 sec.  The concentration of A was kept at 65% for 1.5 min 
before returning it to 10% in 3.5 min, followed by 4.5 min of column re-equilibration.  Positive ESI-MS/MS 
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was performed using the following parameters: ionspray voltage of 5.5 kV, temperature of 500 °C, ion 
source gas 1 set at 25, ion source gas 2 and curtain gas set at 20, collision gas set at medium.  The entrance 
potential (EP), collision energy (CE), and collision cell exit potential (CXP) resulting in the neutral loss of 
507.0 Da from the (M+H)+ precursor (37,38) were individually optimized for free CoA (EP = 10 V, CE = 
37 V, CXP = 15 V), acetyl-CoA (EP = 10 V, CE = 40 V, CXP = 15 V), malonyl-CoA (EP = 12 V, CE = 40 
V, CXP = 15 V), succinyl-CoA (EP = 10 V, CE = 45 V, CXP = 17 V), butyryl-CoA (EP = 12 V, CE = 41 
V, CXP = 20 V), heptanoyl-CoA (EP = 10 V, CE = 45 V, CXP = 20 V), octanoyl-CoA (EP = 7 V, CE = 46 
V, CXP = 23 V), lauroyl-CoA (EP = 9 V, CE = 47 V, CXP = 20 V), heptadecanoyl-CoA (EP = 10 V, CE 
= 47 V, CXP = 20 V), and stearoyl-CoA (EP = 9 V, CE = 50 V, CXP = 23 V).  The declustering potential 
was consistently set at 170 volts.  For all other CoA species, the parameters EP, CE and CXP were set at 
10, 45 and 17 V, respectively.  Retention times for the detected CoA species are reported in supplementary 
Table 3.S2.  Peak analysis was conducted using MultiQuant 3.0.2.  Peak areas corresponding to free CoA 
and acyl-CoAs with an acyl chain up to 10 carbons were normalized to the heptanoyl-CoA internal standard.  
Peak areas corresponding to longer acyl-CoAs and choloyl-CoA were normalized to the heptadecanoyl-
CoA internal standard.  Corrected peak areas were further normalized to the tissue weight.   
Hepatocyte isolation 
For immunofluorescence studies, primary hepatocytes were isolated from fed mice using the two-
step liver perfusion method described by Klaunig et al. (39) with minor modifications.  All perfusion steps 
were conducted at a flow rate of 7 ml/min with buffers kept at 37 °C.  The livers were first perfused with 
50 ml of a modified Krebs buffer (120 mM NaCl, 24 mM NaHCO3, 20 mM glucose, 5 mM HEPES, 4.8 
mM KCl, 1.2 mM MgSO4, 1.2 mM KH2PO4, 100 U/ml penicillin, 100 U/ml streptomycin, 50 µg/ml 
gentamycin) containing 0.1 mM EGTA, pH 7.4, followed by 50 ml of modified Krebs buffer supplemented 
with 1.4 mM CaCl2 and 10 µg/ml of Liberase TM (Sigma-Aldrich). Intermittent clamping of the inferior 
vena cava for about 10 sec each time was conducted during this latter step to increase total cell yield (40).  
After the perfusion, the livers were excised, separated from the gall bladder, and transferred to a sterile dish 
containing 20 ml of the second perfusion buffer, ice-cold, without Liberase.  The cells were released by 
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tearing the liver with forceps. The cell suspension was filtered through a 100 µm strainer (Fisher Scientific) 
and washed 3 times with Waymouth medium (Waymouth MB 752/1 medium supplemented with 0.5 mM 
serine, 0.5 mM alanine, 20 mM HEPES, pH 7.4, 100 U/ml penicillin, 100 U/ml streptomycin, 50 µg/ml 
gentamycin) containing 1.9 mg/ml of fatty acid-free bovine serum albumin and pelleted by spinning at 50 
x g for 2 min at 4°C.  After the washes, the cells were re-suspended in Waymouth medium containing 5% 
newborn calf serum, and 7.5*105 cells were plated on each well of collagen-coated 6-well plates.  Viability 
(consistently >85%) and yield were assessed by counting the cells that excluded trypan blue.  After a 5 h 
incubation, the medium was replaced with fresh Waymouth medium lacking the newborn calf serum and 
an overlay of Matrigel (0.2 mg/ml) and insulin (60 nM) was added as described by Cyphert, H. A. et al. 
(41).  The hepatocytes were incubated under these conditions overnight before being processed for 
immunofluorescence studies. 
For the measurement of the rate of β-oxidation, the procedure for the isolation of hepatocytes was 
modified as follows.  First, hepatocytes were isolated from mice fasted for 15 h (food removed at 4:00 pm) 
using perfusion buffers containing a reduced amount of glucose at 5.5 mM.  Second, after releasing the 
cells from the liver capsule, M199 containing 25 mM of HEPES, pH 7.4 (M199/HEPES) was used for all 
the wash steps and to re-suspend the cells at a final concentration of 1.0 *106 cells/ml.  This cell suspension 
was immediately used for β-oxidation studies. 
Immunofluorescence and β-oxidation 
Confocal microscopy was used as previously described (18) to determine the subcellular 
localization of the exogenous FLAG-tagged Nudt7 expressed in primary hepatocytes isolated from mice 
injected with Nudt7-AAV.  The DYKDDDK antibody, the PMP70 antibody used to visualize the 
peroxisomes, and an Alexa Fluor 647 donkey-anti rabbit secondary antibody were used at a 1:1,000 
dilution. β-Oxidation studies were conducted in triplicate on freshly isolated hepatocytes in suspension by 
measuring the production of 14C-labeled acid-soluble metabolites from [1-14C]-palmitic acid (American 
Radiolabeled Chemicals) in the presence or absence of etomoxir, an inhibitor of mitochondrial fatty acid 
oxidation.  Pilot experiments were conducted to determine the optimal combination of cell number and 
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incubation time that would ensure linear product formation. Furthermore, pilot studies comparing the 
delivery of [1-14C]-palmitic acid as a solution in ethanol or as a dry powder thoroughly resuspended in 
M199/HEPES containing 0.5% fatty acid-free bovine serum albumin ruled out any adverse effect of 17 mM 
final ethanol concentration on the rate of fatty acid oxidation. Specifically, 7.5*105 cells were pre-incubated 
for 15 min at 37 °C in 1.5 ml of M199/HEPES ± 45 µM etomoxir before starting the reaction with the 
addition of 0.5 ml of substrate mixture containing 0.5% fatty acid-free bovine serum albumin and 0.4 mM 
of [1-14C]-palmitic acid (0.4 µCi, specific activity 2 mCi/mmol, from a 111 mM stock solution in ethanol) 
in M199/HEPES.  The hepatocytes were incubated with gentle shaking for 15 min at 37 °C before stopping 
the reaction by transferring 400 µl of cell suspension to a tube containing 133 µl of 1 M perchloric acid.  
This acidified suspension was centrifuged at 20,000 x g for 10 min and the radioactivity in 300 µl of 
supernatant was measured by liquid scintillation counting.  Typical raw counts in samples incubated without 
etomoxir were between 4,000 and 9,000 cpm, while typical raw counts in samples incubated with etomoxir 
were between 1,500 and 3,000 cpm.  Background radioactivity (350-700 cpm), estimated in reactions 
stopped immediately after the addition of the substrate mixture, was subtracted from each sample.  For each 
mouse, peroxisomal β-oxidation was calculated from the samples incubated with etomoxir.  Mitochondrial 
fatty acid oxidation was calculated as the difference between total fatty acid oxidation (no etomoxir) and 
peroxisomal fatty acid oxidation.   
Statistical analysis 
All data are reported as the mean with ± the standard error.  Unless otherwise stated, statistical 
significance (p <0.05) was calculated using the Welch's two-sample t-test (Metabolon Inc.) or the unpaired 
two-tailed Student's t-test and the two-way ANOVA using GraphPad Prism 7 (GraphPad Software).   
Results 
Overexpression of Nudt7 does not prevent the increase in total CoA levels that occurs in fasted livers  
Compared to fed mice, the livers of mice fasted for 24 or 48 h exhibit a higher concentration of 
total CoA (free CoA plus acyl-CoAs) and lower expression of the CoA-degrading enzyme Nudt7, the major 
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CoA diphosphohydrolase isoform in this organ (17,18,22).  To examine the inverse correlation between the 
cofactor concentration and Nudt7 expression in more detail, we measured liver CoA levels and Nudt7 
mRNA and activity during a fasting time course, starting as early as 6 h after the removal of food (Fig. 3.1).  
We found that CoA levels increased significantly after a 12 h fast (Fig. 3.1A) and plateaued after a 24 h 
fast, closely matching the time course of the decrease in Nudt7 mRNA (Fig. 3.1B) and CoA-degrading 
activity (Fig. 3.1C) in the liver.  To determine whether suppression of Nudt7 activity contributed to this 
accumulation of CoA, we overexpressed Nudt7 with an N-terminal FLAG tag in the livers of C57BL/6J 
mice and analyzed the effect of this manipulation on the concentration of hepatic CoA in fasted mice (Fig. 
3.2).  Transgene expression was obtained using AAV particles carrying the Nudt7 coding sequence under 
the control of the liver-specific LP1 promoter (42).  Mice expressing GFP from the same AAV construct 
were used as controls and to characterize the transgene expression from this system, which was stable for 
up to 12 weeks (Fig. 3.2A) and confirmed to be liver-specific (Fig. 3.2B).  All analyses were conducted 3-
4 weeks after the AAV injection.  Under these conditions, values for serum AST and ALT were in the 
normal range (43) and similar between GFP and Nudt7 mice, indicating the absence of liver damage (Table 
3.1).  Furthermore, injection of Nudt7-AAV did not affect food intake or body weight and the weight of the 
liver normalized to body weight was modestly elevated in the Nudt7 mice under fed but not fasting 
conditions (Table 3.1).  Exogenous Nudt7 was robustly overexpressed compared to the endogenous levels 
(Fig. 3.2C, inset) and measurement of the CoA-degrading activity in Nudt7 mice fasted for 24 h revealed a 
10-fold increase in activity compared to either GFP mice or mice that were not injected with AAV (Fig. 
3.2C).  Nudt7 is a peroxisomal enzyme (23,24).  To determine whether the exogenously expressed Nudt7 
was correctly localized to the peroxisomes, we isolated primary hepatocytes from mice injected with Nudt7-
AAV and used immunofluorescence and confocal microscopy to visualize the subcellular localization of 
the FLAG epitope fused to the transgene.  Nuclei were stained with DAPI and peroxisomes were visualized 
with an antibody against the endogenous protein PMP70.  FLAG-tagged Nudt7 was found to co-localize 
with PMP70 with no detectable fluorescence in the cytoplasm (Fig. 3.2D), confirming efficient import of 
this protein into the peroxisomes.  Nudt7 and GFP mice were then analyzed for total hepatic CoA levels in 
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the fed state and following a 24 and 48 h fast.  The hepatic concentration of CoA tended to be lower in fed 
and 24 h fasted Nudt7 mice compared to the GFP controls but the difference did not reach statistical 
significance (Fig. 3.2E).  Furthermore, total CoA levels increased with fasting in both Nudt7 and GFP 
livers, indicating that overexpression of Nudt7 was not able to blunt the accumulation of CoA driven by 
activation of the biosynthetic pathway.  Overall, these results supported the conclusion that the fasting-
induced decrease in Nudt7 activity was unlikely to significantly contribute to the increase in the total CoA 
content normally observed, at the whole tissue level, in the liver (Fig. 3.1).   
Increased Nudt7 activity in the fasted state changes the acyl-CoA composition and affects lipid metabolism 
in the liver 
Nudt7 is a promiscuous CoA diphosphohydrolase that hydrolyzes free CoA and a large range of 
short- and medium-chain acyl-CoAs in vitro (17,18).  To determine whether overexpression of Nudt7 
changed the concentration of individual acyl-CoA species, we analyzed the relative composition of the 
acyl-CoA pool in Nudt7 and GFP livers by LC/MS/MS.   
We found that, upon fasting, the vast majority of the short-chain acyl-CoAs monitored were 
significantly decreased in Nudt7 mice compared to the GFP controls (Fig. 3.3D-F).  These included CoA 
thioesters known to be excellent in vitro substrates for Nudt7, such as acetyl-, propionyl-, (iso)butyryl-, 
hexanoyl-, malonyl-, and succinyl-CoA.  Acetoacetyl-, 3-hydroxyl(iso)butyryl, crotonyl/methacryloyl- and 
tyglyl/methylcrotonyl-CoA, which are products of fatty acid and amino acid metabolism, were also 
decreased in the Nudt7 livers (Fig. 3.3E).  The drop in the concentration of free CoA observed in fasted 
Nudt7 livers narrowly missed statistical significance (Fig. 3.3D).  Choloyl-CoA, an intermediate in bile 
acid synthesis and known substrate of recombinant Nudt7 (17), was significantly decreased by Nudt7 
overexpression in the fasted state and tended to be lower even in the fed state (Fig. 3.3C and F).  
Overexpression of Nudt7 had minimal effects on the acyl-CoA composition in the fed state, with adipoyl-
CoA, a six-carbon dicarboxylic fatty acyl-CoA, being the only CoA thioester significantly decreased in fed 
Nudt7 mice compared to the GFP controls (Fig. 3.3A-C).  Adipoyl-CoA levels remained significantly lower 
in the Nudt7 livers following a 24 h fast.   
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Combined, these results showed that while the overexpression of Nudt7 did not significantly affect 
total CoA levels, it changed the acyl-CoA composition of the liver by decreasing the concentration of short-
chain acyl-CoAs and choloyl-CoA.  This effect was more pronounced in the fasted state, when the 
expression and activity of the endogenous Nudt7 in the liver were lowest (Fig. 3.1B and C).  
Mono and dicarboxylic short-chain acyl-CoAs are products and intermediates of a variety of 
metabolic processes, including lipid, carbohydrate, and amino acid metabolism.  To identify pathways that 
could be potentially altered by Nudt7 overexpression, we conducted global metabolic profiling of Nudt7 
and GFP livers harvested from fed and fasted mice (Fig. 3.4, supplementary Table 3.S1).  As expected, the 
vast majority of the 769 metabolites detected was changed by the nutritional state, regardless of the specific 
transgene expressed (Fig. 3.4A).  The separation between the fed and fasted mice, together with the 
significant overlap between GFP and Nudt7 groups, was also highlighted by principal-component analysis 
(Fig. 3.4B).  In the fed state, 66 metabolites were significantly different between Nudt7 and GFP livers, 
while this number almost doubled to 111 in the fasted state (Fig. 3.4A).  Only a few CoA species, CoA 
precursors and metabolites were detected by the untargeted metabolic profiling.  Among the latter were the 
products of the Nudt7 reaction, phosphopantetheine and 3’,5’-ADP, which were not significantly different 
between Nudt7 and GFP livers, although the higher levels of phosphopantetheine trended toward 
significance in the fasted Nudt7 livers (supplementary Table 3.S1).  The larger effect of Nudt7 expression 
on liver metabolism in the fasted state was consistent with the results from the acyl-CoA analysis (Fig. 
3.3E) and led us to focus all subsequent analyses on this nutritional state. Under fasting conditions, pathway 
enrichment analysis revealed that the 3 most significantly and highly (>3-fold) enriched pathways were 
primary and secondary bile acid metabolism, henceforth considered as a single pathway, and acylcarnitines 
(Fig. 3.4C).  These pathways, which are both part of lipid metabolism and either dependent on or tightly 
linked to CoA, were further analyzed (see below).   
We also conducted RNA-Seq analysis of the livers of fasted Nudt7 and GFP mice.  This analysis 
revealed a modest effect of Nudt7 overexpression on the global transcriptome, identifying a total of 62 
genes (33 upregulated, 29 downregulated) whose expression was significantly different in the Nudt7 livers 
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compared to the GFP controls (fold-change >1.50 or ≤0.66, adjusted p value <0.01) (supplementary Table 
3.S3).  Gene ontology analysis on this list of differentially expressed genes identified carboxylic ester 
hydrolase activity and fibronectin binding as significantly enriched molecular functions (Table 3.2), but no 
significantly enriched biological process.  Pathway analysis using the Wikipathway database identified the 
PPAR signaling pathway as significantly enriched (Table 3.2).  The same result was obtained using the 
KEGG database. 
Effect of increased Nudt7 activity on peroxisomal bile acid metabolism  
A heat plot of all the primary and secondary bile acids detected by the untargeted metabolomics 
analysis is shown in Fig 3.5A. Out of the 23 bile acids quantified, 20 were significantly decreased in the 
livers of Nudt7 mice, with no difference in the levels of the bile acid precursors cholesterol and 7α-
hydroxycholesterol (44).  The concentration of liver and serum cholesterol was also confirmed to be similar 
between GFP and Nudt7 mice by an independent assay (Table 3.1).  To corroborate the results obtained 
from the untargeted metabolomics analysis, we injected another cohort of mice with GFP- and Nudt7-AAV 
and examined the bile acid composition of their livers with a targeted bile acid assay.  This analysis was 
also extended to the gall bladder and small intestine of the mice, as these organs contain a large portion of 
the body bile acid pool.  In the Nudt7 livers, the targeted analysis confirmed a significant ∼50% decrease 
in selected primary and secondary bile acids including tauro-α-muricholic acid, taurocholic acid, 
taurodeoxycholic acid and tauroursodeoxycholic acid compared to the GFP controls (Fig. 3.5B).  Hepatic 
levels of β-muricholic acid and tauro-β-muricholic acid also tended to be lower in the Nudt7 mice but did 
not reach statistical significance in the targeted analysis.  No difference in the bile acid composition of the 
gall bladder and small intestine was detected (Fig. 3.5C and D), indicating that the effect of the increased 
activity of Nudt7 was limited to the liver, the site of bile acid synthesis and Nudt7 overexpression.   
Conversion of the primary bile acid precursors trihydroxycholestanoic acid (THCA) and 
dihydroxycholestanoic acid (DHCA) to cholic and chenodeoxycholic acid, respectively, requires their 
activation as CoA thioesters and import into the peroxisomes, where their branched side chain undergoes a 
 72 
 
cycle of β-oxidation (14) (Fig. 3.5E).  This process requires free CoA and releases propionyl-CoA and 
either chenodeoxycholoyl-CoA (CDCA-CoA, from DHCA-CoA) or choloyl-CoA (from THCA-CoA), 
which are then primarily conjugated to taurine in mice.  In the Nudt7 livers, the observed drop in the 
concentration of cholic acid and its derivatives was consistent with a robust decrease in the levels of 
choloyl-CoA (Fig. 3.3F).  Similar to choloyl-CoA, THCA-CoA is a known substrate of Nudt7 (17); 
however, the concentration of THCA-CoA was below the detection limit of our assay and we could not 
determine whether the Nudt7 livers contained less of this bile acid precursor as well.  At the gene expression 
level, Cyp39a1 was the only gene involved in bile acid metabolism that was differentially expressed and, 
specifically, downregulated, in the Nudt7 livers (supplementary Table 3.S3).  Cyp39a1 encodes a 
microsomal cytochrome P450 enzyme that possesses 7α-hydroxylase activity against 24(S)-
hydroxycholesterol (45), but the contribution of this enzyme to bile acid synthesis in the liver is currently 
unknown.  
Effect of Nudt7 overexpression on fatty acid β-oxidation 
In addition to bile acids, the metabolic profiling of the livers identified 18 acylcarnitines that were 
significantly changed between Nudt7 and GFP mice in the fasted state (Fig. 3.6A).  Acylcarnitines are in 
close equilibrium with acyl-CoAs due to the activity of carnitine acyltransferases that transfer the fatty acid 
from an acyl-CoA to free carnitine to prevent a buildup of acyl-CoAs at the expense of free CoA (46).  
Among the acylcarnitines significantly changed by the overexpression of Nudt7, short-chain acylcarnitines 
such as propionylcarnitine, succinylcarnitine, glutarylcarnitine and adipoylcarnitine were significantly 
decreased, correlating with the global drop in the concentration of short-chain acyl-CoAs observed in the 
Nudt7 livers (Fig. 3.3E).  Conversely, acylcarnitines with acyl chains between 8 and 20 carbons in length 
(C8-20-acylcarnitines) were found to accumulate, suggesting increased transfer of medium and long-chain 
acyl groups from the correspondent acyl-CoAs to free carnitine.  The concentration of free carnitine, which 
is the most abundant of the carnitine species in the liver, was not affected by these changes in the 
composition of the acylcarnitine pool (16,47,48).   
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Since this metabolic signature was consistent with a potential decrease in fatty acid oxidation 
(16,49,50), we measured the rate of 14C-labeled palmitic acid oxidation in primary hepatocytes isolated 
from fasted Nudt7 and GFP mice.  To discriminate between the mitochondrial and peroxisomal pathways, 
we incubated the hepatocytes with and without etomoxir, an inhibitor of mitochondrial carnitine 
palmitoyltransferase 1 and thus, mitochondrial fatty acid oxidation.  Additionally, we measured the serum 
concentration of 3-hydroxybutyrate and glucose, as the circulating levels of these metabolites are linked to 
the oxidation of fatty acids in liver mitochondria through the production of NADH and acetyl-CoA in this 
subcellular compartment (Table3. 1).  We did not detect any significant difference in the rate of 
mitochondrial fatty acid oxidation between groups (Fig 3.6B), and this result correlated with similar levels 
of 3-hydroxybutyrate and glucose in the serum of Nudt7 and GFP mice (Table 3.1).  Conversely, we found 
that increased Nudt7 activity reduced the rate of fatty acid oxidation in the peroxisomes (Fig. 3.6B), the 
subcellular compartment where Nudt7 localized.  Peroxisomes are known to preferentially shorten fatty 
acids instead of completely oxidizing them to acetyl-CoA (51).  Indeed, octanoate undergoes only 1-2 
cycles of peroxisomal fatty acid oxidation to produce hexanoate and butyrate (52).  Consistent with this 
notion, the Nudt7 livers accumulated C8-20-acylcarnitines while exhibiting a lower concentration of acyl-
CoAs and acylcarnitines with 6 carbons or less, which are the final products of the oxidation of 
monocarboxylic fatty acids (hexanoyl- and butyryl-CoA) and dicarboxylic fatty acids (adipoyl- and 
succinyl-CoA) in the peroxisomes (Fig. 3.6C).  The decrease in the levels of these short-chain acyl-CoAs 
could have also been further exacerbated by direct degradation of these products by exogenous Nudt7.   
Overexpression of Nudt7 led to a 2-fold increase in the expression of Acaa1b, the gene encoding 
the peroxisomal enzyme acetyl-coenzyme A acyltransferase 1B, also known as 3-ketoacyl-CoA thiolase B 
(Table 3.2).  Acca1b catalyzes the last, free CoA-dependent step in the oxidation of straight chain fatty 
acids (25,53).  No other gene involved in either peroxisomal or mitochondrial fatty acid oxidation was 
differentially expressed in the Nudt7 livers.  Although peroxisomal fatty acid oxidation was blunted in the 
Nudt7 livers, hepatic triglyceride levels were similar between Nudt7 and GFP mice (Table 3.1).  
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Interestingly, this was associated with the upregulation of genes involved in the hydrolysis of triglycerides 
(Ces1g, Ces1f and Ces2c) (54-56) and monoacylglycerols (Abhd6) (57-59) (Table 3.2).   
Taken together with the effect on bile acid metabolism, the above data indicated that overexpression 
of Nudt7 predominantly affected peroxisomal lipid metabolism. 
Discussion 
In this study, we determined the metabolic consequences of increasing the CoA-degrading activity 
in the liver by overexpressing mouse Nudt7, the most abundant of the currently known CoA 
diphosphohydrolases in this organ (17,18,22).  One of our major findings was that the overexpression of 
the enzyme did not interfere with the increase in total liver CoA levels that occurs in the transition from the 
fed to the fasted state (Fig. 3.2E).  This supports the conclusion that, upon fasting, the rise in CoA observed 
at the whole tissue level is driven by increased synthesis (16), with negligible contribution from a decrease 
in Nudt7 expression and activity (Fig. 3.1B and C).   
The exogenously expressed Nudt7 was correctly localized to the peroxisomes (Fig. 3.2D).  Based 
on subcellular fractionation studies on rat livers, these organelles are estimated to contain only about 4-10% 
of the total hepatic CoA, depending on the nutritional state (11,60).  This subcellular localization combined 
with the fact that overexpression of the enzyme had no significant effect on total liver CoA levels but 
decreased the concentration of choloyl-CoA, a CoA thioester specifically generated in the peroxisomes, 
suggests that the activity of this enzyme may have been restricted to the peroxisomal CoA pool.  This 
conclusion is further supported by the second major finding of this study: increased expression of Nudt7 in 
the fasted state specifically blunted peroxisomal processes, including peroxisomal fatty acid β-oxidation 
(Fig. 3.6).   
Overexpression of Nudt7 in the fed state, when the endogenous Nudt7 levels are highest, had a 
very modest effect on the composition of the hepatic acyl-CoA pool.  Conversely, overexpression of Nudt7 
in the fasted state led to a 15-50% decrease in the concentration of most of the short-chain acyl-CoAs 
detected (Fig. 3.3E).  Short-chain acyl-CoAs, which comprise a small portion of total liver CoA (15,60,61), 
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are excellent substrates for the enzyme (17,18); thus, increased degradation of these CoA species likely 
contributed to lowering their concentration in the Nudt7 livers.  However, this mechanism alone would not 
explain the distinctive accumulation of C8-10-acylcarnitines observed in the same samples (Fig. 3.6A).  This 
metabolic signature was associated with a reduced rate of peroxisomal fatty acid oxidation, which, in turn, 
likely blunted product formation.  Among the products whose concentrations were curtailed were hexanoyl- 
and butyryl-CoA, which derive from the shortening of straight-chain fatty acids, acetyl-CoA, which is 
produced at each cycle of fatty acid oxidation, and both adipoyl- and succinyl-CoA, which are the final 
products of the oxidation of long-chain dicarboxylic fatty acids, a process that preferentially occurs in the 
peroxisomes (52,62-64).  Propionyl-CoA, whose concentration was also significantly decreased in the 
fasted Nudt7 livers, can be produced from the oxidation of 2-methyl-branched-chain fatty acids, another 
process that is restricted to the peroxisomes (14).  The accumulation of acylcarnitines with a wide range of 
acyl chain lengths also suggests that the flux through the whole peroxisomal β-oxidation pathway, and not 
just at a specific step, was decreased in the Nudt7 livers.  This, in turn, correlated with a strong trend towards 
a lower concentration of free CoA, which is required to complete each cycle of fatty acid oxidation and 
might have been limiting in the peroxisomes of the Nudt7 livers due to increased hydrolysis (Fig. 3.3D).  
Analysis of the acyl-CoA pool composition in the peroxisomes would be required to confirm this 
hypothesis; however, the measurement of individual CoA species, and even total CoA, in mitochondria-
free peroxisomal fractions is still technically challenging in mice due to the small sample size.  As observed 
in other mouse models, inhibition of peroxisomal fatty acid oxidation in the Nudt7 livers was also associated 
with the activation of PPARα and with increased transcription of genes involved in lipid transport and 
metabolism (Table 3.2) (65,66).   
Efficient off-loading of acyl chains from CoA to carnitine likely explains why, unlike medium- and 
long-chain acylcarnitines, no change in the concentration of the correspondent acyl-CoAs was detected in 
the Nudt7 livers at the whole tissue level.  For octanoyl- and, possibly, decanoyl-CoA, this process could 
occur inside the peroxisomes by the action of carnitine octanoyltransferase (Crot), which is abundant in 
mouse liver (67-69).  For acyl-CoAs with a C10 acyl group or longer, the formation of acylcarnitines would 
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likely be catalyzed by carnitine palmitoyltransferase 1, following hydrolysis of long-chain acyl-CoAs by 
peroxisomal thioesterases, such as Acot3 or Acot8, and re-activation of the released free fatty acids as acyl-
CoAs outside the peroxisomes (27,67,69,70).  Since CoA species are too bulky to diffuse through the 
peroxisomal membrane (71), the presence of multiple peroxisomal thioesterases and Crot allows the acyl 
group attached to CoA to leave the peroxisomes as free fatty acids or acylcarnitines and enter metabolic 
pathways in other subcellular compartments.  For example, acetate produced from acetyl-CoA inside the 
peroxisomes contributes to the synthesis of malonyl-CoA (52,72), whose levels were correspondingly 
decreased in the Nudt7 livers.  Similarly, the succinyl group derived from the oxidation of dicarboxylic 
fatty acids in the peroxisomes can feed into the TCA cycle (62).  In the livers of the fasted Nudt7 mice, the 
levels of succinyl-CoA and succinylcarnitine were acutely decreased by 40 and 80%, respectively.  In spite 
of this, the concentration of succinate, fumarate, malate, and oxaloacetate was not significantly different 
between Nudt7 and GFP livers (supplementary Table 3.S1), indicating that anaplerosis from amino acid 
metabolism was sufficient to support the portion of the TCA cycle that, together with pyruvate 
carboxylation, produces mitochondrial oxaloacetate for gluconeogenesis.  Accordingly, fasting blood 
glucose levels were similar between Nudt7 and GFP mice (Table 3.1).  Interestingly, Taniguchi M. et al. 
identified an association between Nudt7 expression and the redness of pork meat (73) and subsequently 
showed that overexpression of porcine Nudt7, which is about 70% identical to the murine isoform, leads to 
a significant decrease in heme content during rat L6 myoblast differentiation (74).  Heme biosynthesis starts 
from the condensation of succinyl-CoA and glycine in the mitochondria (75).  The authors suggested that 
that the effect on heme levels could be due to reduced availability of succinyl-CoA, a conclusion supported 
by our data.  Overall, our results strongly suggest that Nudt7 activity contributes to the regulation of the 
levels of acetyl-CoA, succinyl-CoA, and other short-chain acyl-CoAs produced by fatty acid oxidation in 
the peroxisomes. 
In addition to peroxisomal fatty acid oxidation, Nudt7 overexpression in the fasted state also altered 
bile acid metabolism.  In particular, the fasted Nudt7 livers contained lower amounts of both primary and 
secondary bile acids (Fig. 3.5).  This phenotype was associated with a robust decrease in the concentration 
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of choloyl-CoA (Fig. 3.3F), a bile acid precursor produced via β-oxidation of the 2-methylacyl side chain 
of THCA-CoA in the peroxisomes (14,44).  Both THCA-CoA and choloyl-CoA are known substrates for 
Nudt7 (17) and the decrease in the concentration of choloyl-CoA could be due to a combination of 
mechanisms.  These include an increase in direct degradation of choloyl-CoA by Nudt7, increased 
degradation of THCA-CoA, and/or decreased β-oxidation of THCA-CoA, which could not be detected in 
our samples.  No information is available on the ability of Nudt7 to hydrolyze DHCA-CoA and CDCA-
CoA in vitro and neither compound was detected in the GFP or Nudt7 livers.  In spite of this, the robust 
decrease in chenodeoxycholic acid derivatives, including conjugated and unconjugated α- and β-muricholic 
acids, suggests the possibility that these CoA thioesters could be Nudt7 substrates as well.  Combined, the 
drop in the availability of choloyl-CoA and the decrease in the hepatic concentration of both cholic acid 
and chenodeoxycholic acid derivatives suggest that increased Nudt7 activity may have blunted bile acid 
synthesis by interfering with the final, peroxisomal steps of the pathway.   
Once synthesized in the liver, bile acids are immediately secreted and stored in the gall bladder 
until food ingestion leads to the contraction of this small organ to empty the bile into the intestinal tract.  
Most of the bile acids are then re-absorbed in the terminal ileum, secreted into the portal blood circulation, 
and transported back to the liver, where the small amount of bile acids lost in the feces is replenished by de 
novo synthesis (76).  Only about 5% of the total bile acid pool needs to be synthesized by the liver at each 
cycle; thus, a defect in bile acid synthesis would take several fasting-to-refeeding cycles to affect the size 
of the total bile acid pool.  This might explain why, in the fasted Nudt7 mice, the decrease in the bile acid 
content was only detected at the site of synthesis but it did not affect the significantly larger pools contained 
in the gall bladder and small intestine (Fig. 3.5B-D).   
Interestingly, Nudt7 overexpression in the liver also decreased the concentration of secondary bile 
acids, independent of any compositional change in the intestinal bile acid pool.  Secondary bile acids are 
produced in the intestine by de-conjugation and de-hydroxylation of primary bile acids by the gut 
microbiome and arrive to the liver through the enterohepatic circulation (44,76).  Once in the liver, the 
secondary bile acids are activated as acyl-CoAs and re-conjugated to taurine or glycine.  Due to the dual 
 78 
 
localization of the enzyme that catalyzes this amidation reaction, bile acid-CoA: amino acid N-
acyltransferase (Baat), the subcellular site of the secondary bile acid conjugation has been debated to be the 
cytosol or, as for the primary bile acids, the peroxisomes (77-79).  Since there was no detectable amount of 
Nudt7 in the cytosol, the decrease in the concentration of secondary bile acids suggests that at least a portion 
of the correspondent acyl-CoAs was imported in the peroxisomes for conjugation and was hydrolyzed by 
Nudt7.  Combined with the ability of Nudt7 to hydrolyze choloyl-CoA, this would support the conclusion 
that Nudt7 and Baat compete for substrates.  Bile acids are signaling molecules that bind to multiple G 
protein-coupled receptors and nuclear receptors, such as the farnesoid X receptor and pregnane X receptor.  
In spite of this, the decrease in the bile acid content of the liver did not cause any significant changes in the 
expression of those receptors’ known targets, including small heterodimer partner (Nr0b2, SHP) and 
cholesterol 7α hydroxylase (Cyp7a1) (44,76) (supplementary Table 3.S3).  Overall, gene expression was 
only modestly affected in the Nudt7 livers compared to the GFP controls, supporting the conclusion that 
the observed changes in peroxisomal metabolism were a direct consequence of the increased CoA-
degrading activity of Nudt7. 
Peroxisomal fatty acid oxidation and bile acid synthesis are normally activated in the fasted state 
(80,81), when Nudt7 expression is at its lowest.  Altogether, our data support the conclusion that modulation 
of Nudt7 activity by the nutritional state could contribute to the regulation of the output of both pathways.  
Analysis of these processes in the livers of Nudt7-/- mice will be required to further corroborate the role of 
Nudt7 in the regulation of peroxisomal lipid metabolism in this organ.  Generation of the Nudt7-/- mice has 
recently been reported, but the phenotyping of these mice was limited to cartilage and immature murine 
articular chondrocytes, which, in the presence of phytol, showed decreased levels of catalase, suggesting a 
connection to peroxisomal function (82).  Our data also strongly suggest that Nudt7-dependent CoA 
degradation may be limited to the quantitatively small pool of peroxisomal CoA.  Analysis of the total CoA 
concentration in the livers of the fed and fasted Nudt7-/- mice will also be important to determine whether 
Nudt7, and its increased activity in the fed state, is indeed responsible for the decrease in CoA levels that 
occurs, at the whole tissue level, in the transition from the fasted to the fed state.    
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Table and figure legends 
Table 3.1.  Selected features of fed and 24 h fasted GFP and Nudt7 mice.  Values are expressed as the 
mean of 7-8 mice per condition ± SEM. * p ≤ 0.05 relative to GFP under the same nutritional conditions. # 
p ≤ 0.05, ## p ≤ 0.01, and ### p ≤ 0.001 relative to the fed state within GFP or Nudt7 groups.  N/A, not 
applicable. 
Table 3.2.  Over-representation enrichment analysis of the genes differentially expressed between 
Nudt7 and GFP mice in the fasted state.  The analysis was conducted using WebGestalt, as described in 
the ‘Materials and methods’ section.   
Figure 3.1.  Changes in hepatic CoA content, Nudt7 mRNA, and activity with fasting.  Mice were 
fasted for 0-48 h and livers were harvested for the measurement of (A) total hepatic CoA levels, (B) Nudt7 
mRNA, and (C) CoA-degrading activity using the Nudt7 substrate mBB-CoA, as described in ‘Materials 
and methods’.  Data are reported as the mean (horizontal line) of measurements on individual mice (circles) 
± SEM. ##, p<0.01, ###, p <0.001 relative to the fed state at t=0.   
Figure 3.2. Liver-specific overexpression of Nudt7 and GFP and effect on hepatic CoA levels.  
C57BL/6J mice were injected with AAV particles to achieve liver-specific overexpression of FLAG-tagged 
Nudt7 or the control protein GFP.  (A) Western blot analysis of liver homogenates (5 µg of protein) for 
GFP expression at different time points, following the intravenous injection of AAV particles.  (B) Three 
weeks after GFP-AAV injection, western blot analysis of different tissue homogenates (5 µg of protein) 
confirmed that transgene expression was liver-specific.  (C) Liver homogenates obtained from non-injected 
mice or from mice injected with Nudt7- and GFP-AAV were assayed for total CoA-degrading activity.  (C, 
inset) Western blot of liver homogenates (20 µg of protein) obtained from GFP and Nudt7 mice using the 
Nudt7 antibody.  GAPDH was used as loading control in (A), (B), and (C, inset).  Numbers in parenthesis 
represent the number of animals analyzed; data are reported as the mean ± SEM. (D) Primary hepatocytes 
were isolated from Nudt7 mice, fixed and used to visualize the localization of the enzyme using the FLAG 
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antibody and confocal microscopy.  Nudt7 is shown in green and the PMP70 protein, which was used as a 
marker for the peroxisomes, is shown in red.  Cell nuclei were stained with DAPI, shown in blue.  The inset 
in the merged image shows details at a higher magnification.  The results are representative of 2 independent 
experiments. (E) Total CoA measured in the liver of Nudt7 and GFP mice fed ad libitum or fasted for 24 
and 48 h.  Data are reported as the mean (horizontal lines) of measurements on individual mice (circles and 
squares) ± SEM. ###, p <0.001 relative to the fed state.   
Figure 3.3.  Liver acyl-CoA analysis.  Livers isolated from (A-C) fed and (D-F) 24 h fasted Nudt7 and 
GFP mice were analyzed by LC/MS/MS to determine the relative abundance of (A, D) free and acetyl-
CoA, (B, E) short-chain acyl-CoAs and (C, F) medium- and long-chain acyl-CoAs.  Numbers in parenthesis 
represent the number of animals analyzed; data are reported as the mean ± SEM.  *, p <0.05. 
Figure 3.4.  Global metabolic profiling of 24 h fasted Nudt7 and GFP livers.  (A) Number of metabolites 
significantly changed in the Nudt7 and GFP livers by fasting and, within a given nutritional state, by Nudt7 
overexpression.  Under each condition, the numbers in red represent metabolites whose concentrations 
increased and the numbers in blue represent metabolites whose concentrations decreased.  (B) Score plot 
of the principal-component analysis (PCA) obtained using MetaboAnalyst 4.0.  Colored ellipses represent 
95% confidence intervals for each group.  Colored dots represent individual mice.  (C) Top 3 most 
significantly enriched pathways that emerged from the global metabolic profiling. 
Figure 3.5.  Nudt7 overexpression in the fasted state decreases the hepatic bile acid content.  (A) Heat 
plot of all primary and secondary bile acids, plus the bile acid precursors cholesterol and 7α-
hydroxycholesterol, detected by global metabolic profiling.  Targeted bile acid analysis of (B) livers, (C) 
gall bladder extracts, and (D) small intestine. In (B-D), data are reported as the mean ± SEM and numbers 
in parenthesis represent the number of animals analyzed. *, p<0.05.  (E) Scheme of the conversion of 
DHCA-CoA and THCA-CoA to chenodeoxycholic acid (CDCA) and cholic acid derivatives in the 
peroxisomes.  Known substrates of Nudt7 are marked by an asterisk.  Overexpression of Nudt7 was 
associated with a decrease (thick blue arrows) in the concentration of choloyl-CoA (CA-CoA), propionyl-
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CoA (Prop-CoA), and of several primary and secondary bile acids, as detected by either untargeted or 
targeted bile acid analyses.  The decrease in free CoA, which narrowly missed statistical significance 
(p=0.07), is indicated by the thin dashed arrow.  CA, cholic acid; CAS, cholic acid sulfate; CDCA, 
chenodeoxycholic acid; DCA, deoxycholic acid; 7keto-DCA, 7-keto-deoxycholic acid; HDCA, 
hyodeoxycholic acid; 3DHCA, 3-dehydrocholic acid; 6OH-LCA, 6-hydroxy-lithocholic acid; 6oxo-LCA, 
6-oxo-lithocholic acid; G-CA, glycocholic acid; G-βMCA, glyco-β-muricholic acid; HCA, hyocholic acid; 
HDCA, hyodeoxycholic acid; LCA, lithocholic acid; αMCA, α-muricholic acid; βMCA, β-muricholic acid; 
ωMCA, ω-muricholic acid; T-CA, taurocholic acid; T-CDCA, taurochenodeoxycholic acid; T-CDCAS, 
taurochenodeoxycholic acid sulfate; T-DCA, taurodeoxycholic acid; T-αMCA, tauro-α-muricholic acid; T-
βMCA, tauro-β-muricholic acid; T-LCA, taurolithocholic acid; T-HDCA, taurohyodeoxycholic acid; T-
UDCA, tauroursodeoxycholic acid; UDCA, ursodeoxycholic acid. 
Figure 3.6.  Nudt7 overexpression in the fasted state decreases the rate of peroxisomal fatty acid 
oxidation.  (A) Heat plot of all the short-, medium-, and long-chain acylcarnitines, plus free carnitine and 
deoxycarnitine, detected by global metabolic profiling.  (B) Primary hepatocytes were isolated from fasted 
Nudt7 and GFP mice and incubated with [1-14C]-palmitic acid in the presence or absence of etomoxir, as 
described in ‘Materials and methods’.  Data are reported as the mean (horizontal bars) of measurements on 
individual mice (circles and squares) ± SEM. *, p<0.05.  (C) Schematic representation of the oxidation of 
medium- and long-chain acyl-CoAs (C8-20-acyl-CoAs) to short-chain acyl-CoAs in the peroxisomes.  
Known substrates of Nudt7 are marked by an asterisk.  The half-filled circle indicates that some C8-20-acyl-
CoAs (i.e. octanoyl- and lauroyl-CoA) are good substrate of Nudt7, but some others (i.e. stearoyl-CoA) are 
not.  A decrease in the rate of peroxisomal fatty acid oxidation in the Nudt7 livers correlated with a decrease 
in the concentration of short-chain acyl-CoAs and correspondent carnitines (thick blue arrows), together 
with the accumulation of C8-20-acylcarnitines.  The decrease in free CoA missed statistical significance 
(p=0.07) and this is indicated the thin dashed arrow.  Acylcarnitines derived from peroxisomal acyl-CoAs 
can be formed directly in the peroxisomes or outside the organelles, following the release of the acyl groups 
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as free fatty acids.  Unlike acyl-CoAs, which are too bulky, the acylcarnitines formed inside the 
peroxisomes can leave the organelles (71).   
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Tables and figures 
Table 3.1.  Selected features of fed and 24 h fasted GFP and Nudt7 mice.    
 Fed 24 h Fast 
 GFP Nudt7 GFP Nudt7 
Serum ALT (mg/dL) 21 ± 2 18 ± 1 35 ± 4 # 24 ± 3 
Serum AST (mg/dL) 48 ± 6 36 ± 7 67 ± 9 62 ± 9 # 
Blood glucose (mg/dL) 98 ± 6 105 ± 6 61 ± 3 ### 55 ± 3 ### 
Serum 3-hydroxybutyrate 
(mM) 
0.31 ± 0.04 0.38 ± 0.08 1.63 ± 0.15 ### 1.57 ± 0.08 ### 
Serum triglycerides (mg/dL) 119 ± 18 144 ± 10 86 ± 6 83 ± 4 ### 
Serum cholesterol (mg/dL) 106 ± 8 90 ± 6 67 ± 6 ## 68 ± 3 ## 
Food intake (g/mouse/day) 4.4 ± 0.5 4.9 ± 0.2 N/A N/A 
Body weight (g) 30.0 ± 0.5 30.8 ± 0.2 24.2 ± 0.3 ### 24.3 ± 0.6 ### 
Liver weight/body weight 
(mg/g) 
44.6 ± 1.9 50.3 ± 1.7* 35.5 ± 1.4 ## 39.4 ± 1.4 ### 
Liver triglycerides (mg/g) 0.9 ± 0.2 0.9 ± 0.1 19.4 ± 1.9 ### 24.1 ± 6.0 ## 
Liver cholesterol (mg/g) 0.6 ± 0.1 0.5 ± 0.1 1.1 ± 0.1 ### 0.9 ± 0.10 ## 
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Table 3.2.  Over-representation enrichment analysis of the genes differentially expressed between 
Nudt7 and GFP mice in the fasted state.  
Molecular function: carboxylic ester hydrolase activity (term: GO: 000052689) 
Fold enrichment: 10.7, p=0.0000171, FDR= 0.004 
Gene symbol Gene name Fold change, Nudt7/GFP 
Car2 Carbonic anhydrase 2 2.11 
Ces1e Carboxylesterase 1E 1.61 
Ces1f Carboxylesterase 1F 1.98 
Ces1g Carboxylesterase 1G 2.11 
Ces2c Carboxylesterase 2C 3.17 
Abhd6 Abhydrolase domain containing 6 1.81 
 
Molecular function: fibronectin binding (term: GO: 0001968) 
Fold enrichment: 29.4, p=0.00013, FDR= 0.015 
Gene symbol Gene name Fold change, Nudt7/GFP 
Itgb3 Integrin beta 3 0.48 
Sdc4 Syndecan 4 0.66 
Lrrc15 Leucine rich repeat containing 15 0.48 
   
Pathway: PPAR signaling pathway (ID: WP2316) 
Fold enrichment: 9.4, p=0.00015, FDR= 0.025 
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Supplementary Table 3.S1. Global metabolic profiling   
Table S1_Global 
metabolic profiling.x 
Supplementary Table 3.S2. Acyl-CoA LC/MS/MS parameters 
Table 
S2_CoA_LC_MS_MS_  
Supplementary Table 3.S3. Nudt7-AAV RNAseq results 
Table S3_RNAseq 
results.xlsx  
 
 
 
  
Gene symbol Gene name Fold change, Nudt7/GFP 
Cd36 CD36 antigen 2.32 
Cyp4a12b 
Cytochrome P450, family 4, subfamily a, 
polypeptide 12B 
1.96 
Pltp Phospholipid transfer protein 1.55 
Scd1 Stearoyl-Coenzyme A desaturase 1 2.20 
Acaa1b Acetyl-Coenzyme A acyltransferase 1B 2.02 
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Figure 3.1. Changes in hepatic CoA content, Nudt7 mRNA, and activity with fasting.   
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Figure 3.2. Liver-specific overexpression of Nudt7 and GFP and effect on hepatic CoA levels.   
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Figure 3.3. Liver acyl-CoA analysis.   
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Figure 3.4. Global metabolic profiling of 24 h fasted Nudt7 and GFP livers.  
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Figure 3.5. Nudt7 overexpression in the fasted state decreases the hepatic bile acid content.   
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Figure 3.6. Nudt7 overexpression in the fasted state decreases the rate of peroxisomal fatty acid 
oxidation.  
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Chapter IV: Conclusions and future directions 
A multitude of research has been dedicated to and has confirmed that CoA is essential. Loss of 
CoA synthesis leads to drastic, negative consequence due to reduced flux through key metabolic pathways, 
disruption of gene regulation, and loss of protein regulation. Switching between the fed and fasted state 
requires dynamic adjustment of CoA synthesis. Synthesis of CoA in the liver increases in the fasted state 
to support the switch from glucose oxidation to fatty acid oxidation and gluconeogenesis to continue to 
provide energy for the body (1-3). Upon synthesis, CoA is distributed among the cytosol/nucleus, 
mitochondria, and peroxisomes to participate in the metabolic pathways in these subcellular compartments. 
It has remained unclear if the CoA pool in each compartment is regulated independently of CoA 
biosynthesis in the cytosol to modulate internal metabolic pathways. In the last decade, two CoA degrading 
enzymes were discovered in mammals. These enzymes were determined to be members of the Nudix 
hydrolase super-family, specific for only CoA, and to localize to the peroxisomes (4-7). Nudt7 and Nudt19 
are expressed almost exclusively in the liver and kidneys, respectively, two very metabolically active 
organs. The objectives of this thesis were to use in vitro and in vivo biochemical approaches to: 1) determine 
the structural and biochemical properties of Nudt7 and Nudt19 and 2) identify the physiological role that 
Nudt7 plays in liver CoA regulation and metabolism.  
Conclusions of chapter II 
We first focused on the biochemical characterization of Nudt7 and Nudt19 using enzymatic assays, 
mutagenesis, and molecular modeling to characterize both proteins. Two key findings of this approach were 
the identification of chenodeoxycholic acid (CDCA) as a competitive inhibitor of Nudt19 but not Nudt7 
and the determination that the CoA box and Nudix box motifs of the active sites were not interchangeable 
between the two enzymes. These findings led to the conclusion that even though both enzymes catalyze the 
same reaction, Nudt7 and Nudt19 exhibit distinct regulatory properties and likely possess different CoA-
binding site and may be used for different purposes in the liver and kidneys, respectively. For example, bile 
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acid synthesis and β-oxidation of very long chain fatty acids occur in the liver peroxisomes. As we have 
shown through our in vivo studies, Nudt7 may be present in the peroxisomes for the localized regulation of 
CoA levels to increase or decrease the flux through theses pathway depending on the nutritional state. 
Nudt19 may assist in regulating β-oxidation or other peroxisomal metabolic processes in the kidneys.  
Future directions of chapter II 
While molecular modeling was a useful resource to get an idea of the structure of Nudt19, it is not 
without limitations. There is currently no crystal structure for Nudt19 and the crystal structure of the human 
NUDT7 contains no bound substrate (8). Thus, our modeling of the Nudt19 structure may not be fully 
accurate. While our mutagenesis studies are consistent with the computational models that were generated, 
there will likely be inaccuracies about the exact positioning of the free CoA substrate its interactions with 
amino acids that we did not test. Solving the crystal structure of Nudt19 and generating crystal structures 
of both enzymes with substrate will be key to determining exact differences in the active sites and substrate 
binding. This approach may also be useful in determining if Nudt19 has any other domains that can interact 
with other proteins or metabolites for regulation. 
 Unlike Nudt7, Nudt19 levels do not change between nutritional states and it is still unknown if 
there is a post-translational mechanism that can regulate its activity. One possible way that the activity of 
Nudt19 and its involvement in peroxisomal metabolism may be through regulation of import into the 
peroxisomes. Import of peroxisomal matrix proteins is a fairly complex process as these proteins are 
synthesized in the cytosol and then imported into the peroxisomes in a fully folded confirmation (9). Many 
peroxisomal proteins, including Nudt7 and Nudt19, contain a C-terminal PTS1 sequence that binds to 
peroxisomal biogenesis factor 5 (Pex5) initiating the formation of a pore in the peroxisomal membrane and 
import of the protein into the lumen of the organelle (10). There are still many poorly understood steps in 
this process. Recently, it has been discovered that ubiquitination plays a role in stabilization of Pex5 for 
protein import and deubiquitination allows Pex5 to be recycled back to the cytosol (11-13). This mechanism 
may aid regulating amount of Nudt19 translocated to peroxisomes depending on the requirement of CoA 
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in this organelle under different nutritional conditions. Another possible way that Nudt19 may be regulated 
is through CoAlation. CoAlation is a recently discovered covalent attachment of CoA to cysteine residues 
of proteins (14,15). This type of modification has been discovered on a variety of different proteins under 
various conditions, modifies the activity of these proteins, and is reversible. Nudt19 contains nine cysteine 
residues so it is possible that one of these residues could be modified by CoA. Isolation of peroxisomes and 
cytosol from fed and fasted kidneys and analysis via Western blot may be one way of determining if Nudt19 
is regulated through either of these mechanisms. Western blot analysis of the various subcellular 
compartments could show changes in the amount of Nudt19 in different subcellular compartments in the 
different nutritional states indicating that Nudt19 peroxisomal import is regulated. We can also attempt to 
immunoprecipitate Nudt19 from the peroxisomes and blot with antibodies against ubiquitin and CoA to see 
if the protein itself is post-translationally modified by either of these.  
Conclusions of chapter III 
Next, we began to elucidate the physiological role of Nudt7 by overexpressing Nudt7 in the liver. 
While overexpression of Nudt7 did not affect the total CoA pool in the liver, it did significantly decrease 
select short chain acyl-CoAs and choloyl-CoA, a CoA species formed only in the peroxisomes. These 
results are consistent with substrate specificity of Nudt7 in vitro. Furthermore, the increase in acyl-CoA 
species correlated with a decrease in two peroxisomal pathways that rely heavily on free CoA, β-oxidation 
and bile acid synthesis. Finally, these changes in acyl-CoA levels and metabolic pathways were only 
observed in the fasted state when endogenous Nudt7 levels decrease significantly. Our findings suggest that 
Nudt7 activity is important for regulating select acyl-CoA species in the liver and the decrease in CoA 
degrading activity may be required for the increase in peroxisomal β-oxidation and bile acid synthesis 
during the fed to fasted transition.  
Future directions of chapter III 
While we now have initial evidence on the involvement of Nudt7 in liver metabolism, the next 
steps will be to confirm these findings in our Nudt7-/- mouse model. We already detect a similar trend in 
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these mice, in that there is no change in total hepatic CoA levels, but we detect an increase in short chain 
acyl-CoA species that were decreased by Nudt7 over-expression (unpublished data). Our published data 
point to regulation of the peroxisomal CoA pool only; however, confirmation of this hypothesis will require 
analysis of the size and composition of the CoA pools in the subcellular compartments between wild type 
and Nudt7-/- mice. This analysis will allow us to see if the changes observed at the whole tissue level are 
due to changes in the composition of the peroxisomal CoA pool.  As of now, it is technically very difficult 
to isolate intact peroxisomes that are not contaminated by mitochondria while still isolating enough of the 
organelles to detect acyl-CoAs in this CoA pool. Peroxisomes contain the smallest pool of CoA (about 4-
10%), which makes it a challenge to detect individual CoA species in this compartment. Future method 
development will be essential for getting a better perspective of changes in metabolites, especially CoA 
species, within this subcellular compartment. The best approach would be to use an immunoprecipitation 
procedure such as that developed by Chen et. Al (16).  Unlike typical subcellular fractionation procedures, 
this technique is much faster, yields more material, and is more specific. Almost all organelle isolation 
methods take several hours resulting in loss of material and changes in metabolite composition (17). This 
is particularly troublesome for peroxisomes, which are extremely fragile and have been found to open and 
close during long isolation procedures resulting in the isolation of peroxisomal ghosts (18). Also, even 
under the most stringent conditions, there is still contamination of the “purified” organelles from other 
subcellular compartments.  Typical fractionation procedures also require buffers that are generally 
incompatible with downstream applications such as mass spectrometry. Developing an 
immunoprecipitation procedure specific for peroxisomes would allow us to overcome these technical 
difficulties and analyze the changes in metabolites within these organelles. Nevertheless, since the 
previously developed immunoprecipitation procedure has been optimized for mitochondria, the conditions 
of the homogenization and immunoprecipitation itself may still need further optimization to support 
isolation of the peroxisomes. The same problem may still arise in a peroxisomal-specific 
immunoprecipitation with the isolation of empty peroxisomes due to their ability to open and reclose.  
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 Finally, in order to gain a broader perspective on the requirement of Nudt7 in the liver and its 
involvement in metabolic diseases, it will be important to use a nutritional mechanism in the Nudt7-/- mice 
to challenge the peroxisomal metabolic pathways and determine any adverse effects (or benefits) that may 
result from less Nudt7 activity in the liver.  Nutritional studies in mice that mimic the Western (or fast food) 
diet use a combination of high fat and high cholesterol (19,20). Both would challenge the peroxisomal 
pathways regulated by Nudt7; high fat would challenge the β-oxidation pathway and cholesterol would 
challenge the bile acid synthesis. Lack of Nudt7 may have differing effects for challenging these two 
pathways.  Less Nudt7 in the peroxisomes would lead to increased free CoA in the Nudt7-/- mice, increasing 
peroxisomal β-oxidation and decreasing triglyceride accumulation in the liver. Therefore, these mice may 
be protected from the effects of the high fat in the Western diet. Alternatively, less Nudt7 could increase 
bile acid synthesis leading to an increase in cholesterol absorption from the diet.  
The discovery that Nudt7 was involved in regulating bile acid synthesis was novel and surprising. 
As with most other metabolic pathways, bile acid synthesis is tightly regulated through transcriptional 
regulation of cholesterol 7alpha-hydroxylase (Cyp7a), the rate limiting enzyme of bile acid synthesis in the 
liver. The results of Chapter III show that regulation of a metabolite for various enzymes that require it also 
limit the flux through the metabolic pathway. The limitation to this overexpression study was that Nudt7 
was overexpressed in adult mice, long after the enterohepatic bile acid pool was established. Once 
established, it is very difficult to affect the size of the total bile acid pool due to efficient reabsorption of 
bile acids in the small intestine (21). It will be interesting to analyze the composition and size of the bile 
acid pool in the Nudt7-/- mice to observe how CoA degradation can affect the bile acid synthesis during the 
establishment of this pool. Based on the current results, it is highly likely that a decrease in CoA degradation 
will enhance the size of the peroxisomal CoA pool and therefore increase bile acid synthesis and the size 
of the total bile acid pool. While this type of change may not lead to detectable whole-body changes under 
“normal conditions”, it may lead to alterations under nutritional challenges such as a Western diet. Future 
studies such as this may establish Nudt7 and the availability of CoA as a second key regulatory mechanism 
in bile acid synthesis. 
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One of the most widely accepted methods of metabolic regulation is through transcriptional 
regulation of various enzymes involved in the numerous metabolic pathways (22). Recent studies, such as 
the one discussed in Chapter III, are beginning to show that metabolic intermediates and cofactors also play 
an important role in regulating metabolic pathways. Previous studies have shown that levels of cofactors 
such as CoA can affect cellular processes such as gluconeogenesis. To our knowledge, this study is the first 
to show that degradation of CoA can play a pivotal role in regulating CoA in one subcellular compartment 
independently of other compartments and that this regulation can lead to changes in organelle specific 
metabolic pathways. However, there are still many unknowns about CoA degradation and how it may affect 
other organs and metabolic pathways. 
While we were able to establish that loss of Nudt19 in mice resulted in a significant increase in 
CoA in the fed state, we still observed a decrease in CoA upon refeeding that was also observed in the livers 
of mice lacking Nudt7 (unpublished data). The fact that accumulated CoA levels rapidly decrease upon 
refeeding even in the absence of the major CA degrading enzyme of that organ and lack of compensation 
by the other peroxisomal isoform indicates that there may be other yet undiscovered CoA degrading 
enzymes. For example, an uncharacterized Nudix hydrolase called Nudt8 has been annotated as a 
mitochondrial enzyme and is closely related to Nudt7 (23,24). We have recently shown that Nudt8 is indeed 
a new CoA-degrading enzyme, which could play a key role in the regulation of  the mitochondrial CoA 
pool (25). It will be useful in the future to generate Nudt7/Nudt19 double knockout mouse models as a 
better approach to discovering other CoA-degrading enzymes. These undiscovered enzymes may be 
responsible for the decrease in CoA levels observed in the transition from fasting to feeding in the absence 
of Nudt7 and Nudt19. Indeed, Nudt7 and Nudt19 are localized to the peroxisomes and based on our Nudt7 
overexpression study are most likely important for regulating the peroxisomal CoA pool and peroxisomal 
processes. In addition to the mitochondria, there may additional CoA-degrading enzymes in the cytosol, or 
even the endoplasmic reticulum to also regulate their (acyl)-CoA pools independently of CoA biosynthesis.  
One other future avenue of research that will be useful would be to study Nudt7, Nudt19, and other 
identified CoA degrading enzymes in the PanK1-/- mice or HoPan treated mice. From studies in these two 
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mouse models of impaired CoA biosynthesis, we know that CoA levels significantly decrease in the liver 
and kidney leading to detrimental effects on glucose metabolism. Knocking out Nudt7 in parallel with 
Pank1 or HoPan treatment could result in two possible results: 1) lack of Nudt7 could rescue the significant 
decrease in CoA and associated hypoglycemia in the liver, indicating that Nudt7 is the CoA degrading 
enzyme responsible for the metabolic changes observed in these mice and that the peroxisomal CoA-
degradation can affect mitochondrial processes in certain situations or 2) these mice will maintain the same 
decrease in hepatic CoA and blood glucose indicating that a different enzyme may be another key player in 
regulating CoA levels. Further characterization of the known CoA-degrading enzymes and discovering 
other CoA-degrading enzymes that may have the capacity to offset the CoA biosynthetic pathway may 
assist in developing novel ways to counteract high and dysregulated CoA levels associated with metabolic 
diseases. Overall, there is still much to be learned about how and why CoA degradation occurs and its 
impact on metabolism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 104 
 
References 
1. Zhang, Y.-M. M., Chohnan, S., Virga, K. G., Stevens, R. D., Ilkayeva, O. R., Wenner, B. R., Bain, 
J. R., Newgard, C. B., Lee, R. E., Rock, C. O., and Jackowski, S. C. (2007) Chemical knockout of 
pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme 
A homeostasis. Chemistry & biology 14, 291-302 
2. Leonardi, R., Rehg, J. E., Rock, C. O., and Jackowski, S. (2010) Pantothenate Kinase 1 Is Required 
to Support the Metabolic Transition from the Fed to the Fasted State. PloS one 5 
3. Garcia, M., Leonardi, R., Zhang, Y.-M., Rehg, J. E., and Jackowski, S. (2012) Germline Deletion 
of Pantothenate Kinases 1 and 2 Reveals the Key Roles for CoA in Postnatal Metabolism. PloS one 
7 
4. Gasmi, L., and McLennan, A. (2001) The mouse Nudt7 gene encodes a peroxisomal nudix 
hydrolase specific for coenzyme A and its derivatives. The Biochemical journal 357, 33-38 
5. Ofman, R., Speijer, D., Leen, R., and Wanders, R. J. C. (2006) Proteomic analysis of mouse kidney 
peroxisomes: identification of RP2p as a peroxisomal nudix hydrolase with acyl-CoA 
diphosphatase activity. The Biochemical journal 393, 537-543 
6. Reilly, S. J., Tillander, V., Ofman, R., Alexson, S. E., and Hunt, M. C. (2008) The nudix hydrolase 
7 is an Acyl-CoA diphosphatase involved in regulating peroxisomal coenzyme A homeostasis. J 
Biochem 144, 655-663 
7. Pierpoint, W. S., and Hughes, D. E. (1954) The synthesis of coenzyme A by Lactobacillus 
arabinosus 17-5. Biochemical Journal 56, 130-135 
8. Tugwood, J., Issemann, I., Anderson, R., Bundell, K., McPheat, W., and Green, S. (1992) The 
mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking 
sequence of the rat acyl CoA oxidase gene. The EMBO journal 11, 433-439 
9. Hasan, S., Platta, H. W., and Erdmann, R. (2013) Import of proteins into the peroxisomal matrix. 
Front Physiol 4, 261 
10. Baker, A., Lanyon-Hogg, T., and Warriner, S. L. (2016) Peroxisome protein import: a complex 
journey. Biochem Soc Trans 44, 783-789 
11. Wang, W., Xia, Z. J., Farre, J. C., and Subramani, S. (2017) TRIM37, a novel E3 ligase for PEX5-
mediated peroxisomal matrix protein import. J Cell Biol 216, 2843-2858 
12. El Magraoui, F., Brinkmeier, R., Mastalski, T., Hupperich, A., Strehl, C., Schwerter, D., Girzalsky, 
W., Meyer, H. E., Warscheid, B., Erdmann, R., and Platta, H. W. (2019) The deubiquitination of 
the PTS1-import receptor Pex5p is required for peroxisomal matrix protein import. Biochim 
Biophys Acta Mol Cell Res 1866, 199-213 
13. Platta, H. W., Brinkmeier, R., Reidick, C., Galiani, S., Clausen, M. P., and Eggeling, C. (2016) 
Regulation of peroxisomal matrix protein import by ubiquitination. Biochim Biophys Acta 1863, 
838-849 
14. Ley, S. C., and de Carvalho, L. P. S. (2017) Protein CoAlation: a redox-linked post-translational 
modification. Biochem J 474, 2897-2899 
15. Gout, I. (2018) Coenzyme A, protein CoAlation and redox regulation in mammalian cells. Biochem 
Soc Trans 46, 721-728 
16. Chen, W. W., Freinkman, E., Wang, T., Birsoy, K., and Sabatini, D. M. (2016) Absolute 
Quantification of Matrix Metabolites Reveals the Dynamics of Mitochondrial Metabolism. Cell 
166, 1324-1337 e1311 
17. Satori, C. P., Kostal, V., and Arriaga, E. A. (2012) Review on recent advances in the analysis of 
isolated organelles. Anal Chim Acta 753, 8-18 
18. Antonenkov, V. D., Sormunen, R. T., and Hiltunen, J. K. (2004) The behavior of peroxisomes in 
vitro: mammalian peroxisomes are osmotically sensitive particles. American Journal of Physiology 
- Cell Physiology 287 
 105 
 
19. Merat, S., Casanada, F., Sutphin, M., Palinski, W., and Reaven, P. D. (1999) Western-type diets 
induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase 
aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol 
levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol 19, 1223-1230 
20. DeLeve, L. D., Wang, X., Kanel, G. C., Atkinson, R. D., and McCuskey, R. S. (2008) Prevention 
of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis. Am 
J Pathol 173, 993-1001 
21. Chiang, J. Y. (2013) Bile acid metabolism and signaling. Compr Physiol 3, 1191-1212 
22. Desvergne, B., Michalik, L., and Wahli, W. (2006) Transcriptional regulation of metabolism. 
Physiol Rev 86, 465-514 
23. Carreras-Puigvert, J., Zitnik, M., Jemth, A. S., Carter, M., Unterlass, J. E., Hallstrom, B., Loseva, 
O., Karem, Z., Calderon-Montano, J. M., Lindskog, C., Edqvist, P. H., Matuszewski, D. J., Ait 
Blal, H., Berntsson, R. P. A., Haggblad, M., Martens, U., Studham, M., Lundgren, B., Wahlby, C., 
Sonnhammer, E. L. L., Lundberg, E., Stenmark, P., Zupan, B., and Helleday, T. (2017) A 
comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase 
family. Nature communications 8, 1541 
24. Calvo, S. E., Clauser, K. R., and Mootha, V. K. (2016) MitoCarta2.0: an updated inventory of 
mammalian mitochondrial proteins. Nucleic acids research 44, D1251-1257 
25. Kerr, E. W., Shumar, S. A., and Leonardi, R. (2019) Nudt8 is a novel CoA diphosphohydrolase 
that resides in the mitochondria. FEBS Letters  
 
